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Since its discovery in 1994, the adipose tissue hormone leptin has been well established 
as a key regulator of energy balance in mammals. However, little is known about the 
molecular evolution of the hormone and its function in non-mammalian vertebrates. 
This project builds on the recent identification of leptin in an amphibian, the tiger 
salamander, to investigate the leptin signalling system in a laboratory salamander, the 
axolotl. The overall aim of the project was to obtain cDNA sequences of the axolotl 
leptin and leptin receptor (LEPR) genes, to analyse their expression and to study their 
expression due to nutritional state. Cloning the axolotl LEPR was a key component of 
the work because no sequence information was previously available. Semi-degenerate 
primers were used to clone a 248 bp fragment of the LEPR, which shared 62% identity 
with human leptin at the amino acid level. Attempts to obtain the full-length cDNA 
sequence were unsuccessful. However, the sequence grouped in proximity to a Xenopus 
LEPR in a phylogenetic tree, and Northern hybridization revealed a transcript size of 
approximately 3 kb, which corresponded with that of other vertebrate LEPRs. To 
establish the expression pattern of leptin and the LEPR between tissues, quantitative 
real-time PCR was performed in two different age groups of animals. In adults, the 
highest expression of leptin was observed in the fat, brain and heart whereas in juveniles 
leptin expression was significantly higher in the fat body compared to all other tissues. 
The highest expression of LEPR was found in the brain and skeletal muscle. These 
findings agree with the main sites of leptin and LEPR expression in mammals, Xenopus, 
and fish providing further evidence that the gene fragments cloned represents the axolotl 
leptin and LEPR. In order to understand the possible role(s) of leptin in the regulation of 
food intake and energy metabolism in amphibians, changes in leptin and LEPR 
expression due to nutritional state were investigated. Short-term fasting did not result in 
any significant changes in leptin expression in the fasted animals, nevertheless it 
showed a tendency towards a lower leptin and LEPR expression of fasted axolotls. 
These findings indicate that the regulation of leptin expression by nutritional state more 
closely resemble the situation in other ectotherms such as teleost fish. This work 
provides the opportunity to explore how the physiological functions of leptin have 
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The leptin gene was discovered using positional cloning in the mouse in 1994 and its 
product was described as an adiposity factor that circulates in the blood in proportion to 
energy stored as fat (Zhang et al., 1994). Before this, several different theories had been 
postulated for how the control of energy balance is controlled in mammals. One theory 
proposed that temperature controls food intake (Brobeck, 1948) while the glucostatic 
theory claimed that energy stores are regulated by the plasma glucose level (Mayer, 
1955) A third theory was called the lipostatic theory. This proposed that the amount of 
energy stored as body fat depot is regulated by the central nervous system, with a 
product of fat metabolism circulating in plasma and affecting food intake and energy 
expenditure to maintain a constant body weight, by interacting with the hypothalamus 
(Kennedy, 1953). The possibility that one of the components of the signalling system 
circulates in bloodstream was shown by Hervey (1959) in experiments on rats where the 
circulatory systems of lean and obese animals were surgically joined (parabiosis).  
The gene that was later identified as the leptin gene was discovered in 1950 as a genetic 
defect which led to mice becoming obese when homozygous for the mutation (Ingalls et 
al., 1950). This mouse mutant was termed the obese or ob/ob mouse. A link with the 
lipostatic theory was made from experiments by Coleman (1973) on the ob/ob mouse, 
and a related mutant, the db/db mouse. Both disorders are characterized by hyperphagia, 
obesity, hyperglycemia and hyperinsulinemia, associated with pancreatic changes. 
When adult ob/ob mice were parabiosed to normal mice, the ob/ob mice lost weight. 
This finding showed that a weight-regulating factor from the blood of the normal mice 
could modify the obesity. The result suggested that the ob/ob mouse did not produce 
sufficient satiety factor to regulate food intake and energy expenditure. A similar 
investigation on paired normal mice with db/db mice showed that normal mice rejected 
food and died of starvation. This suggested that db/db mice produced a satiety factor, 
but they did not respond to it. The db/db phenotype appears to reflect a defect in the 
action of a receptor. Consistent with the results of these experiments, ob/ob mice paired 
with db/db mice reduced their food intake and lost weight. So the ob/ob mice appeared 
to respond to the putative excess of ob protein produced by their db/db partners 
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(Coleman, 1973). It was evident that a satiety factor produced by adipose tissue had yet 
to be discovered. 
 
1.2 Leptin in mammals 
 
1.2.1 Discovery of leptin 
 
The leptin gene was discovered by Friedman and colleagues in 1994 by cloning and 
sequencing of the mouse ob/ob gene using positional cloning techniques (Zhang et al., 
1994).  In this important paper, they determined that the ob/ob gene is expressed in 
adipose tissue and encodes a 167 amino acid protein that has the characteristics of a 
secreted hormone. The obese mutation in mice, was shown to be a result of a nonsense 
mutation associated with an absence of RNA encoding the hormone. Southern 
hybridization of a mouse obese gene probe to genomic DNA from mammals (mouse, 
rat, rabbit, vole, cat, cow, sheep, pig and human) and non-mammalian vertebrates 
(chicken and eels) showed that at moderate stringency, there were detectable signals in 
all vertebrate DNAs tested. A human orthologue of the obese gene was also identified 
and alignment of the predicted human and mouse amino-acid sequences showed 84% 
overall identity. The conservation of the obese gene among vertebrates suggested that 
the function of its encoded protein is highly conserved.  
 
After the original paper describing the cloning of the obese gene was published, the 
hypothesis was tested that the Ob protein is involved in regulation of energy balance by 
observing the effects of administering it in ob/ob mice. Several studies showed that 
intraperitoneal injection of normal and ob/ob mice with recombinant Ob protein 
decreased their body weight, percent body fat, food intake, and serum concentrations of 
glucose and insulin. In addition, metabolic rate, body temperature, and activity levels 
were increased by this treatment (Campfield et al., 1995; Pelleymounter et al., 1995; 
Halaas et al., 1995; Stephens et al., 1995). Central administration of Ob protein into the 
lateral or third brain ventricle lowered food intake and body weight of ob/ob and diet-
induced obese mice but not in db/db obese mice. These results suggest that Ob protein 
can act directly on neuronal networks that control feeding and energy balance 
(Campfield et al., 1995; Stephens et al., 1995). Because administration of the Ob protein 
reversed obesity in ob/ob mice, Halaas et al. (1995) proposed that it should be given the 
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name leptin, derived from the Greek leptos, meaning thin. Stephens et al. (1995) 
showed that one mechanism by which this protein regulated food intake was inhibition 
of neuropeptide Y expression, a neuropeptide which stimulates food intake, decreases 
thermogenesis and increases plasma insulin and corticosterone levels.  
 
Other studies performed soon after the discovery of leptin showed that obese humans 
and rodents are still able to produce leptin RNA and the level of leptin protein is higher 
than in lean individuals. These data suggest that obesity may be a consequence of leptin 
resistance, rather than insufficient amounts of leptin itself (Maffei et al., 1995; 
Considine et al., 1995; Lönnqvist et al., 1995; Hamilton et al., 1995). 
 
1.2.2 Structure of the leptin gene and leptin protein 
 
The mouse leptin gene and its human homologue encodes a 4.5 kb adipose tissue 
mRNA with a highly conserved 167-amino acid open reading frame (Chmurzynska et 
al., 2003). The leptin gene consists of three exons separated by two introns with the 
coding sequence in exons 2 and 3, and a minor fraction of the leptin mRNA contains an 
extra, untranslated, exon between exons 1 and 2 (He et al., 1995, Figure 1). The first 
exon and the first intron arise in the 5’-untranslated region (UTR) (Chmurzynska et al., 
2003). The first exon is located ~7.5 kb upstream of the 175-bp exon 2. Intron 2 is ~1.7 
kb long and codes for 48 amino acids. Exon 3 is at least 2.5kb in size and consists of the 
coding region (codes for 118 or alternatively 119 amino acids) and 3’UTR (Isse et al., 
1995). Exon 2 is more conserved then exon 3. It codes for the amino acids of the 
helix responsible for binding leptin to its receptor (Chmurzynska et al., 2003). 
 
The promoter contains a TATA motif occurs upstream of exon 1 at 229 to 234 
nucleotide position (He et al., 1995). The Sp1 consensus sequence (GGGCGG) was 
found at 295 to 2100. Between 249 and 258 is a short palindrome CCAAT/enhancer 
that is predicted to bind C/EBP motifs (a transcription factor important in adipose cell 
differentiation). Co-transfection with the C/EBP motif caused a significant increase in 
leptin reporter expression, which suggests that C/EBP can activate the promoter of 






Figure 1 Structure of the mouse leptin gene (modified from He et al., 1995). Diagram 
showing the intron (thin line)/ exon (thick line) structure. Exons are shown in red and 
their coding regions in black. The arginine codon, which is mutated in ob/ob mice, is 
marked at aa position 105. 
 
The leptin protein is approximately ~16kDa in mass and belongs to the class-I helical 
cytokine family, a large group of signalling molecules (Huising et al., 2006). The leptin 
protein structure (Figure 2) consists of four antiparallel -helices (A, B, C and D) and is 
similar to that of the long-chain helical cytokine family, which includes granulocyte 
colony-stimulating factor (G-CSF), leukaemia inhibitory factor (LIF) and ciliary 
neurotropic factor (CNTF). The extra-cellular domain of the leptin receptor shows 
homology to receptors of the  G-CSF, LIF and CNTF, which belongs to the same group 
of class-I helical cytokines (Huising et al., 2006).  
 
Figure 2 Tertiary structure of human leptin, PDB accession 1AX8. Segment 85-119, 
responsible for appetite suppression and weight loss in obese mice, is shown in green, 




1.2.3 Leptin receptor  
 
The db/db, or diabetes, strain of obese mouse referred to above was, like the ob/ob 
mutation, discovered at the Jackson Laboratory (Hummel et al., 1966).  Coleman’s 
parabiosis studies on normal mice paired with db/db mice showed that normal mice 
rejected food and died of starvation. This suggested that db/db mice produce a satiety 
factor, but do not respond to it. Therefore, the db/db phenotype appeared to reflect a 
defect in the action of a receptor (Coleman, 1973). 
 
The leptin receptor (LEPR, also known as the obese receptor or ObR) was identified by 
Tartaglia et al. (1995) shortly after the discovery of leptin.  To search for a LEPR, 
leptin-alkaline phosphatase (AP) fusion proteins were generated and used to screen 
mouse tissues and cell lines. Leptin binding was identified in the choroid plexus, which 
was used to prepare a cDNA expression library. The library was screened with a leptin-
AP fusion protein to identify a LEPR, consisting of 5.1 kb with an 894-amino acid open 
reading frame. The mouse sequence was used to identify a human orthologue that 
shared 78% amino acid identity. The mature protein consisted of an extracellular 
domain which is 816 amino acids long, followed by a transmembrane domain (23 
amino acids) and a short cytoplasmic domain (34 amino acids) (Tartaglia et al., 1995). 
Soon after the discovery of the LEPR, it was discovered that the db/db mutation consists 
of a single substitution in the LEPR (Chen et al., 1996). This provided the link between 
the db/db mutation and the LEPR that had been suggested by Coleman’s experiments. 
 
The LEPR is a cell surface receptor belonging to the cytokine receptor superfamily 
which plays an important role in mammalian body weight homeostasis and energy 
balance (Huising et al., 2006). A variety of LEPR isoforms have been discovered, which 
are products of alternative splicing at the 3’-end of gene transcript. They are divided 
into three groups: the complete protein – long form; short forms; and a soluble binding 
protein consisting of the extra-cellular domain. The full length LEPR isoform 
containing the extracellular and transmembrane domains together with intracellular 
motifs is considered to be the fully functional receptor. In additional, shorter, isoforms 
the intracellular domain is truncated or absent (Richards and Poch, 2003). In the mouse, 
the splice variants of the receptor consist of six different isoforms, commonly referred 
to in the literature as LEPRa-f (Cioffi et al., 1996) (Figure 3). Of these, the Re form is 
the soluble binding protein, while forms Ra, Rc, Rd and Rf share the same intracellular 
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and transmembrane domains but have an intracellular domain of different lengths. The 




Figure 3 Mouse leptin receptor isoforms (Ceddia, 2005). All six receptors share 
identical extracellular ligand-bind domains but are differentially spliced at the C 
terminus resulting in proteins with different cytoplasmic domains. Only Ob-Rb is the 
functional receptor. The intra-cellular domain includes conserved motifs (boxes 1-2), 
which take part in binding of Janus kinase (JAK), as part of the signal transduction 
pathway. The cytoplasmic domain contains unique tyrosine phosphorylation sites 
(Y985, Y1077, Y1138). Ig=immunoglobulin domain; CRD=cytokine receptor domain; 
Fn3=fibronectin III domain (Ceddia, 2005). 
 
The LEPR long form consists of three regions: an extracellular domain, a 
transmembrane domain and an intra-cellular domain (Huising et al., 2006). The 
extracellular region contains the putative leptin binding site and a pair of repeated 
tryptophan/serine motifs (WSXWS), which have been shown to be required for receptor 
folding, but not involved in ligand binding.  The intracellular domain includes three 
conserved motifs (boxes 1-3), which take part in binding of Janus kinase (JAK) as part 
of the signal transduction pathway, as well as unique tyrosine phosphorylation sites 
(Tartaglia, 1997). The LEPR exists constitutively as a dimer in the cell membrane, 
which is required for intracellular signalling. Each receptor in the pair is bound to a 
leptin molecule (Devos et al., 1997). The binding of the ligand to the receptor, which 
requires the presence of an intact intracellular domain, induces intracellular signalling 
by the Janus kinase and signal transducer and activator of transcription (JAK-STAT) 
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pathway. JAKs phosphorylate tyrosine residues on the receptor, which interact with 
STATs, and are themselves tyrosine-phosphorylated by JAKs. These phosphorylated 
tyrosines create docking sites for other STATs, mediating their dimerisation. Activated 




Figure 4 Leptin receptor signalling pathway in hypothalamus (Rahmouni and Haynes, 
2004). Leptin modulates gene transcription via activation of signal transducer and 
activator of transcription (STAT) proteins, phosphoinositol 3 kinase (PI3-K), and 
extracellular factor-regulated kinase (ERK) (Rahmouni and Haynes, 2004). 
 
In addition to generating transcripts with cytoplasmic domains of different length, 
alternative splicing of the LEPR also generates variants with different 5’ untranslated 
regions. In one of these, an alternative AUG initiation codon starts a distinct open 
reading frame encoding a putative protein named leptin receptor gene-related protein 
(OB-RGRP), also known as leptin receptor overlapping transcript (LEPROT) (Bailleul 
et al., 1997; Huang et al., 2001). The protein was first identified in humans by analysis 
of a large expressed sequence tag database. Genomic organization and cDNA sequence 
comparisons indicate that the LEPROT gene shares its promoter and two exons with the 
LEPR gene, however the protein does not share amino acid sequence similarity in the 
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open reading frame to the LEPR itself (Bailleul et al., 1997). A related gene identified in 
humans, LEPROT1, has 70% amino acid sequence similarity with LEPROT (Huang et 
al., 2001). Using in situ hybridisation the distribution of LEPROT mRNA overlapped 
closely with LEPR mRNA in the mouse brain (Mercer, et al., 2000). However, a 
different pattern of expression was observed in the placenta, suggesting a difference in 
promoter activity. 
 
A link between LEPROT and LEPR expression has been suggested by experiments 
where LEPROT has been overexpressed or silenced in cell culture (Couturier et al., 
2007). These demonstrated that LEPROT negatively regulates the cell-surface 
expression of the LEPR. Moreover, in vivo silencing of LEPROT in the mouse 
prevented the onset of diet-induced obesity (Couturier et al., 2007). 
 
1.2.4 Functions of leptin - introduction  
 
The initial conception of the physiological role of leptin was the regulation of energy 
balance in mammals (Zhang et al., 1994). The physiological role of leptin was seen as 
rising with increasing adiposity to generate a signal that limits further weight gain. A 
greater amount of hormone is produced and secreted as fat storage increases. Leptin's 
effects on body weight are mediated through effects on hypothalamic centres that 
control feeding behaviour and hunger, body temperature and energy expenditure. It is 
actively transported into the brain where it acts on the hypothalamus to reduce food 
intake and increase energy expenditure. The initial view, that leptin functions primarily 
as an anti-obesity hormone, required revision as a result of new data which showed that 





Figure 5 Role of leptin in the regulation of body weight and other functions (modified 
from Rahmouni and Haynes, 2004) 
 
1.2.5 Functions of leptin - energy balance 
 
As discussed in 2.1 above, experiments soon after the discovery of leptin established 
that leptin acts directly on neuronal networks that control feeding and energy balance, 
indicating that it is a signal to the brain of body fat content. However, it was apparent 
from a study by Ahima et al. (1996) that it is falling, rather than rising, blood 
concentrations of leptin that are the most physiologically relevant physiological signal. 
Leptin gene expression and blood leptin concentrations are reduced by fasting (Fredrich 
et al., 1995; Ahima et al., 1996; Grinspoon et al., 1997; Andersen et al., 1997). Leptin 
deficient ob/ob mice show a physiological state characteristic of starvation and this can 
be generally reversed by administering leptin (Halaas et al., 1995). Also, in normal 
mice, physiological changes associated with starvation can be reduced by providing 




Studies reviewed above indicated that leptin decreases food intake when injected either 
peripherally or centrally, and a primary site of action within the brain was suggested by 
the demonstration that the LEPR is expressed in the hypothalamus (Tartaglia et al., 
1995). In order to reach the brain circulating leptin must cross the blood-brain barrier 
(BBB). To investigate how this occurs, administration of leptin labelled with 
125
I was 
performed (Banks et al., 1996). The results were visualised using autoradiography, 
which showed localization of leptin in vivo in the choroid plexus and arcuate nuclei of 
the hypothalamus after injection. This study indicated that circulating leptin reaches the 
central nervous system via a saturable active transport process across the BBB. The 
system was inhibited by unlabeled leptin, however unlabeled tyrosine and insulin, 
proteins also known to have saturable transport systems, did not affect the influx of 
leptin.  This indicates that the saturable transport system for leptin is different and 
specific (Banks et al., 1996). Similar results were demonstrated by Golden et al. (1997), 
where an in vitro experiment was performed using a model of human blood-brain 
barrier. The study showed binding of mouse recombinant 
125
I- leptin in isolated human 
brain capillaries (Golden et al., 1997). Within the hypothalamus leptin activates the 
central melanocortin signalling pathway through the arcuate nucleus of the 
hypothalamus (ARC) by modulating the activity of neuropeptide Y and 
proopiomelanocortin neurons (Fan et al., 1997, Huszar et al., 1997, Lin et al., 2000). 
Within the arcuate nucleus, signalling from the LEPR acts on two groups of neurons: 
the anorexigenic peptide Cocaine and Amphetamine Related Transcript (CART) and the 
large precursor peptide proopiomelanocortin (POMC), which reduce food intake, while 
the other the orexigenic peptides neuropeptide Y (NPY) and agouti related protein 
(AgRP), which increase food intake (Lin et al., 2000). Leptin decreases NPY/AgRP 
expression (Lewis et al., 1993; Mizuno and Mobbs, 1999; Stephens et al., 1995) and in 
contrast, stimulates POMC neurons and expression of this protein (Cowley et al., 2001). 
Moreover, the synaptic density onto NPY and POMC neurons in arcuate nuclei differs 
between ob/ob and wild type mice (Pinto et al., 2004). In the ob/ob animals, excitatory 
synapses on NPY neurons are more numerous compared to wild-type mice, where they 
have significantly more inhibitory synapses. The amount of synapses onto the POMC 
neurons is lower in ob/ob mice. Pinto and colleagues (2004) provide evidence, that 
leptin changes neuronal connections in the arcuate nucleus: it was shown in ob/ob mice 
that there was a significant decrease in the total number of synapses onto NPY neurons 
and increase in those onto POMC neurons after leptin injection (Pinto et al., 2004). 
These findings suggest that leptin action in hypothalamus involves altered and co-
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ordinated expression of key neuropeptide genes, and implicate leptin in the 
hypothalamic response to fasting. 
 
1.2.6 Functions of leptin - leptin and human obesity 
 
The physiological role of leptin in the regulation of body weight makes it relevant to the 
pathogenesis of human obesity (Zhang et al., 1994; Flier 1995; Rink 1994). Circulating 
leptin concentrations were seen as rising with increasing adiposity to generate a signal 
that limits further weight gain (Zhang et al., 1994). Therefore, this hormone has been 
considered as a new pharmacological approach to the treatment of human obesity 
(Thorburn et al., 2000; Sinha and Caro 1998; Lee et al., 2002). However, clinical trials 
based on leptin administration to obese patients, have not shown significant weight loss 
in the subjects (Heymsfield et al., 1999). These studies demonstrate that obese people 
are insensitive to leptin rather than being leptin deficient. Although autosomal recessive 
mutations in the leptin gene (ob/ob; db/db) are responsible for obesity in mouse models 
(Zhang et al. 1994; Friedman and Halaas 1998), leptin or its receptor gene defects are 
rare in human obesity (Maffei et al., 1996, Carlsson et al., 1997). It is been 
demonstrated that obese people have much higher expression level of leptin in adipose 
tissue than non-obese subjects in the absence of leptin gene mutation (Lönnqvist et al., 
1995; Hamilton et al., 1995). This finding suggests that obese people are insensitive to 
the function of the obese gene product and excess leptin does not reduce food intake or 
increase energy expenditure. This state has been termed leptin resistance (Hamilton et 
al., 1995). Several mechanisms underlying leptin resistance have been identified. These 
mechanisms can be divided into three steps: the transport of leptin across the blood-
brain barrier (BBB), defect of the LEPR, and disturbance of receptor signalling 
pathway. In order to reach the brain circulating leptin must cross the blood-brain barrier 
(BBB) (Banks et al., 1996). The short form of the LEPR mediates this transport 
however in obese people the level of this receptor is lower and it contributes to the 
leptin resistance (Shimizu et al., 2002). It has been shown that leptin level in 
hypothalamus compared to the plasma level is lower in obese subjects (Schwartz et al., 
1996; Dӧtsch et al., 1997). Another mechanism involved in leptin resistance is a 
negative control of LEPR signalling pathway (Yasukawa et al., 2000). Molecules like 
SOCS-3 (member of the suppressors of cytokine signalling family) (Bjorbaek et al., 
1998), SHP-2 (downregulates Jak2/STAT3 activation by leptin in the hypothalamus) 
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(Carpenter et al., 1998; Zhang et al., 2004) and (PTP)-1B (protein tyrosine phosphatase) 
(Cheng et al., 2002) act as inhibitors of leptin signalling. Several mechanisms 
underlying leptin resistance have been discovered however the cascade of the events is 
still unknown. Although the initial idea of leptin as an anti-obesity drug failed, there is 
still interest in manipulating the leptin signalling system in order to manage body 
weight in obese patients. New approaches to enhance leptin signalling and increase 
leptin sensitivity include reduction of SOCS3 activity, inhibition of PTP-1B or 
manipulation of POMC and activation of melanocortin receptors (Foster-Schubert et al., 
2006). Another idea to overcome the effects of leptin resistance is to combine leptin 
with potential leptin sensitizers like pramlintide, an amylin analogue. It has been 
demonstrated that this combination causes significantly more weight loss than either 
treatment alone (Ravussin et al., 2009). Further research is needed to reveal whether 
leptin has a role in weight loss maintenance. 
 
1.2.7 Functions of leptin - leptin and seasonal fattening cycles 
 
One area of research into leptin’s effects on energy balance in mammals has focused on 
species which show natural seasonal cycles of adiposity, food intake and energy 
balance. Studies on Siberian and Djungarian hamsters (Phodopus sungorus and 
Phodopus campbelli) (Klingenspor et al., 1996; Mercer 1998), sheep (Ovis aries) 
(Adam and Mercer 2004), blue fox (Alopex lagopus) (Mustonen et al., 2005), Iberian 
red deer (Cervus elaphus hispanicus) (Gaspar-Lopez et al., 2009), woodchuck 
(Marmota monax) (Concannon et al., 2001), European brown bear (Ursus arctos arctos) 
(Hissa et al., 1998), and raccoon dog (Nyctereutes procyonoides) (Nieminen et al., 
2001) demonstrate that leptin concentrations increase in long days (summer) which is 
associated with  weight gain and high food intake, and that leptin levels decrease in 
short days (winter) when food intake and animal weight is reduced. This appears 
paradoxical in relation to what is known about leptin in laboratory rodents, because high 
levels of leptin might be expected to be associated with the lean state.  However, 
seasonal body weight cycles are associated with seasonal changes in sensitivity to 
leptin. Effects of leptin administration in short days are greater than in long days, when 
the animals show insensitivity to leptin (Mercer et al., 2001, Adam and Mercer 2001; 
Rousseau et al., 2003). These results suggest that the animals show a phenomenon of 
seasonal leptin resistance regulated by photoperiod (Adam and Mercer, 2001). 
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Therefore seasonal fattening in mammals appears to involve the regulation of 
hypothalamic pathways independent of leptin. 
 
1.2.8 Functions of leptin - leptin and metabolism 
 
In addition to leptin’s role in energy homeostasis, it can regulate glucose and insulin 
homeostasis via the central nervous system (Pelleymounter et al., 1995). Inhibitory 
effects on hepatic glucose production (Pocai et al., 2005; van den Hoek et al., 2008) and 
stimulation of glucose uptake in skeletal muscle (Cusin et al., 1998; Haque et al., 1999; 
Kamohara et al., 1997; Minokoshi et al., 1999) were observed after 
intracerebroventricular injection of murine leptin. Moreover, leptin dramatically 
improves insulin sensitivity in human lipodystrophy (Oral et al., 2002; Petersen et al., 
2002; Shimomura et al., 1999). The signalling effects of insulin and leptin on glucose 
homeostasis are linked because both hormones activate the enzyme 
phosphatidylinositol- 3-OH kinase (PI3K) in the hypothalamus (Niswender et al., 2001, 
Morton et al., 2005, Minokoshi et al., 2004). To investigate leptin and insulin activation 
of PI3K, intracerebroventricular (i.c.v.) injections of leptin and histochemical and 
biochemical methods were performed (Niswender et al., 2001, Niswender et al., 2003). 
The studies have shown an increase in hypothalamic PI3K activity connected with the 
insulin receptor substrate IRS, which activates cell-surface receptors of the tyrosine-
kinase type (Niswender et al., 2001). Insulin stimulates tyrosine phosphorylation of IRS, 
which binds to PI3K and activates another protein kinase (Niswender et al., 2003, 
Morton et al., 2005). The results suggest that PI3K takes part in the signal transduction 
pathway which leads to reduced appetite. Moreover, these findings indicate that both 
insulin and leptin play an important role in the food intake regulation by hypothalamic 
activity (Nisweder et al., 2001)  
 
1.2.9 Functions of leptin - reproduction 
 
Leptin is an important signal in the regulation of neuroendocrine function and fertility, 
interacting with the reproductive axis at multiple sites. The lack of leptin in ob/ob mice 
results in infertility (Coleman, 1982); however exogenous leptin injections to ob/ob 
mice restore fertility (Chebab et al., 1996; Rosenboum and Leibel 1998; Ahima et al., 
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1997). Leptin has been found as a hormone that plays a role in reproductive organs, 
such as the gonads (Karlsson et al., 1997; Caprio et al., 1999), endometrium (Kitawaki 
et al., 2000), placenta (Hoggard et al., 1997; Masuzaki et al., 1997), and mammary 
gland (Smith-Kirwin et al., 1998), with related influences on important physiological 
processes such as menstruation (Ludwig et al., 2000), pregnancy, and lactation 
(Mounzih et al., 1998). It has been shown that leptin is involved in hypothalamic and 
pituitary regulation of gonadotropin secretion by stimulation of GnRH (gonadotropin-
releasing hormone) release. Leptin stimulates directly luteinizing hormone (LH) and 
follicle-stimulating hormone (FSH), release by the pituitary via nitric oxide (NO) 
synthase activation in gonadotropes (Yu et al., 1997). 
 
 
Figure 6 Schematic diagram illustrating the interaction of leptin with the hypothalamic-
pituitary-gonadal axis and endometrium (Machos et al., 2002) 
 
A number of studies have shown that leptin administration advances the time of 
puberty. An increase in leptin levels may be the signal of the initiation of puberty 
(Chehab et al., 1997). Animal experiments and observations have revealed significant 
variation in leptin levels throughout the menstrual cycle, with higher levels in the 
midluteal rather than follicular phase. This finding suggests the action of ovarian 
steroids on production of the leptin in adipose tissue (Ludwig et al., 2000). Leptin is 
15 
 
also involved in regulating maternal nutrition and the metabolic adaptation of nutrient 
partitioning during pregnancy and lactation. Pregnancy, as an energy-consuming 
process, appears to be a state of leptin resistance (Mounzih et al., 1998). Leptin may 
also be important in regulation of the male reproductive axis. Recent studies show that 
leptin is able to act at different levels of the hypothalamic-pituitary-testicular axis.  It 
inhibits directly the signal for testicular steroidogenesis, which may be relevant to 
observations of decreased testosterone secretion in obese men (Tena-Sempere et al., 
2001). In conclusion, leptin may act as a link between adipose tissue and the 
reproductive system, showing that sufficient energy reserves are required for normal 
reproductive function. 
 
1.2.10 Functions of leptin - development 
 
Several studies have implicated leptin in the growth and development of the fetus, both 
through placental and fetal expression of the leptin and LEPR genes. The leptin gene 
and mature leptin protein are produced in a number of tissues in the fetal mouse, where 
leptin may be multifunctional and have both paracrine and endocrine effects (Hoggard 
et al., 1997).  It may act as a fetal growth factor or a signal to the fetus of maternal 
energy status. Other possible roles of leptin in the placenta may be stimulation of 
placental angiogenesis and a local autocrine immunomodulatory or anti-inflammatory 
role (Takahashi et al., 1999). A number of studies have shown that umbilical cord blood 
leptin levels are positively correlated with fetal insulin, birth weight, length and head 
circumference (Schubring et al., 1996). These findings suggest a potential function of 
leptin in fetal growth. Several studies have reported that leptin is involved in the 
modulation of bone mass during skeletal development (Heaney et al., 1996). The 
hormone is an important stimulator of cortical bone formation in obese mice. In 
growing ob/ob mice, administration of leptin results in a dramatic increase of bone 
formation (Steppan et al., 2000). Both body weight and fat mass have been correlated to 
bone mineral density (Felson et al., 1993). The long form of LEPR has been found in 
chondrocytes and osteoblasts (Steppan et al., 2000), which suggests that leptin may play 
a role as a physiological signal between bone and fat mass: it may serve as a signal to 




Leptin also plays a role in lung development. It is produced by lipofibroblasts (Torday 
et al., 2002), cells located in the alveolar walls (Rehan et al., 2006), which are involved 
in lung protection against oxygen free-radicals (Torday et al., 2001), and in regulation 
of pulmonary surfactant production (Torday and Rehan, 2002).  Furthermore, leptin 
induces an increase of air space diameter by stimulation of lung epithelial cell surfactant 
phospholipid synthesis (Torday and Rehan, 2002). The ability to raise the surfactant 
production induced by stretch is especially vital in diving animals (Hall et al., 2009).  In 
addition, leptin signalling activates TACE (Tumor Necrosis Activating Factor), an 
enzyme important in the function of epidermal growth factor receptor (EGF-R) involved 
in development and regulation of role of the alveolar blood gas barrier (Nielsen et al., 
2009). Leptin is involved in the stretch-induced surfactant production pathway, which is 
essential for diving animals to increase ability of the lungs to stretch under hydrostatic 
pressure and to prevent collapse of the lungs (Miller et al., 2006). Cloning and 
sequencing of the seal leptin genes (grey Halichoerus grypus and harbour Phoca 
vitulina seals) have shown non-synonymous substitutions in regions of the leptin 
molecule that are conserved in other vertebrate groups (Hall et al., 2009). It has been 
hypothesised that the unusual positive selection of leptin in seals is associated with a 
change in leptin function to meet the increased demand for pulmonary surfactant in 
these species (Hall et al., 2009; Torday et al., 2010). Neural development is also 
influenced by leptin (Ahima et al., 1999; Steppan and Swick 1999, Udagawa et al., 
2006; Bouret et al., 2004). The brains of mutant mice (ob/ob; db/db) differ from the 
wild type controls (Bereiter and Jeanrenaud, 1979). The structural abnormalities in 
obese mice include reduced volume and weight of brain, cell density and proliferation 
activity, as well as alterations in the dendritic orientation of hypothalamic neurons and 
immature pattern of expression of synaptic and glial proteins (Ahima et al., 1999; 
Steppan and Swick 1999). Exogenous administration of leptin can increase total cell 
number in brain and repair these impairments (Ahima et al., 1999). These results imply 
that leptin raises proliferation activity in neural stem/progenitor cells, and induces 
neuronal differentiation and migration (Udagawa et al. 2006). Moreover, LEPR is 
expressed in the cingulate cortex (Diano et al., 1998), a part of the brain responsible for 
motor and cognitive processes (Vogt et al., 1992). This finding agrees with observations 
on mutant mice (ob/ob, db/db), which showed reduced locomotor activity and changed 
cognitive functions (Pelleymounter et al. 1995, Campfield et al. 1995; Halaas et al. 
1995). In addition, leptin stimulates formation and neural projections of neurons in the 
arcuate nucleus associated with feeding circuits (Bouret et al., 2004). The above 
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evidence demonstrates leptin’s importance for controlling structural and functional 
brain development. 
1.2.11 Functions of leptin - immune response 
 
Leptin production dramatically increases during infection and inflammation, suggesting 
that leptin, as a long-chain helical cytokine, plays a role in inflammatory-immune 
response and the host defence mechanism (Grunfeld et al., 1996; Sarraf et al., 1997; 
Faggioni et al., 1998). Leptin stimulates the production of pro-inflammatory cytokines 
from cultured monocytes and enhances the production of Th1 type cytokines from 
stimulated lymphocytes (Otero et al., 2006). Leptin also plays a role in inflammatory 
processes involving T cells and has been reported to modulate T-helper cell activity in 
the cellular immune response (Lord et al., 1998; Martin-Romero et al., 2000). Leptin 
deficient (ob/ob) mice, show increased susceptibility to infections (Meade et al., 1979; 
Chandra 1980), and are resistant to TH 1-mediated experimental autoimmune diseases 
including encephalomyelitis, arthritis, glomerulonephritis, colitis and hepatitis (La Cava 
and Matarese 2004). Also, several studies have implicated leptin in the pathogenesis of 
autoimmune inflammatory conditions, such as experimental autoimmune 
encephalomyelitis, type 1 diabetes, rheumatoid arthritis, and intestinal inflammation 
(Otero et al., 2005). These findings provide evidence that leptin links the 
neuroendocrine and the immune system because of its dual nature as a hormone and 
cytokine. Leptin appears to have a dual effect of stimulating immunity against infection, 
while promoting the development of autoimmunity. 
 
It has also been shown that leptin and LEPR are involved in the production of multiple 
blood cell lineages and hematopoiesis (Bennet et al., 1996; Faggioni et al., 2000; 
Umemoto et al., 1997; Cioffi et al., 1996; Hirose et al., 1998). Alterations in normal and 
db/db mutant mice demonstrate that leptin and its receptor play an important role in 
hematopoietic differentiation. db/db mice have a deficit in lymphopoietic progenitors 
and faulty erythrocyte production in the spleen, however the level of erythrocytes in 
blood is normal (Bennet et al., 1996). These findings suggest that leptin might act at the 
level of the hematopoietic progenitor cell. Moreover, a decrease in the concentration of 
lymphocytes and an increase in monocytes have been reported in ob/ob mice (Faggioni 
et al., 2000). Studies on colony forming assays in the culture of bone morrow cells have 
shown that leptin activates generation of granulocyte-macrophage in both normal and 
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db/db mice; however the effect in db/db mice is significantly reduced (Umemoto et al., 
1997). In addition, it is been observed that leptin enhances the activity of stem cell 
factor and erythropoietin (Umemoto et al., 1997). These results agree with the LEPR 
expression pattern, showing that the long form of LEPR is expressed in hematopoietic 
stem cells and a variety of hematopoietic cell lnes (Cioffi et al., 1996). Furthermore, 
leptin has a proliferative effect on BAF-3 cells, which leads to an increase in the 
proliferation of hematopoietic stem cell populations (Bennet et al., 1996). The above 
studies demonstrate that LEPR signalling stimulates the proliferation of hematopoietic 
progenitors. 
 
1.2.12 Functions of leptin - cardiovascular system 
 
Leptin can contribute to different cardiovascular actions, although sympathoactivation is 
probably the most important. The hormone causes a significant increase in overall 
sympathetic nervous activity, which is correlated with increased expression of 
neuropeptides such as POMC and corticotropin-releasing hormone (Rahmouni et al., 
2003). A selective leptin resistance may explain how leptin is involved in obesity-
related hypertension, despite loss of its metabolic effects (Rahmouni et al., 2004). These 
observations suggest that the cardiovascular actions of leptin may help explain the link 
between excess fat mass and cardiovascular diseases.  
 
It has been demonstrated both in vitro and in vivo, that leptin is involved in 
angiogenesis (Bouloumié et al., 1998, Fukuda et al., 2003, Sierra-Honigmann et al., 
1998, Cao et al., 2001, Anagnostoulis et al., 2008). Experiments performed on cultured 
human umbilical venous endothelial cells (HUVECs) showed that leptin induces cell 
proliferation, development of capillary-like tubes and neovascularisation (Bouloumié et 
al., 1998). Moreover, leptin stimulates the secretion of vascular permeability 
factor/vascular endothelial growth factor (VEGF) which promotes angiogenic processes 
(Bouloumié et al., 1998, Anagnostoulis et al., 2008, Cao et al., 2001). This finding 
suggests that leptin signalling, generated by LEPR expressed in human vasculature and 





1.3 Leptin in invertebrates 
 
It is currently uncertain whether leptin signalling systems are present in invertebrates. 
Jiang et al. (2010) reported the cloning of a leptin receptor-like sequence in the Chinese 
Mitten Crab (Eriocheir sinensis) that shared sequence identity with invertebrate 
sequences deposited in databases including sea squirt (Ciona intestinalis) 
(XP_002128678), parasitic wasp (Nasonia vitripennis) (XP_001605479), red flour 
beetle (Tribolium castaneum) (XP_973202), pea aphid (Acyrthosiphon pisum) 
(BAH70994), triatomid bug (Rhodnius prolixus) (AAQ20841) and sea lice (Caligus 
clemensi; Caligus rogercresseyi) (ACO14858; ACO11244). The sequence also appears 
to share similarities and conserved amino acids with other amino acid LEPR sequences 
from vertebrates including the Vps domain and three cysteine residues, critical for 
fundamental structure and function of the LEPR. RT-PCR analysis revealed expression 
of the LEPR-like sequence in crab tissues linked to nutrition and reproduction, 
including the intestine and hepatopancreas, and in the gonad and accessory gonad (Jiang 
et al. 2010). However the existence of LEPR-like molecules in invertebrates should be 
interpreted with caution. Liongue and Ward (2007) point out that the evolutionary 
divergence of Class I cytokine receptors means that phylogenetic trees and alignments 
are sometimes unreliable. For example, Kurokawa et al. (2009) state that the 
XP_002128678 sea squirt sequence that Jiang et al classified as a LEPR, is actually a 
LEPROT and that the LEPR is absent in sea squirts, suggesting that the LEPROT arose 
earlier in evolution. The sequencing of the sea squirt genome has allowed comparison 
of this invertebrate chordate with vertebrate genomes. Orthologues of JAK, STAT and 
SOCS are present in the sea squirt genome, suggesting that cytokine signalling pre-dates 
vertebrates (Hino et al., 2003). Liongue and Ward (2007) searched for Class I cytokine 
receptors in the seq squirt using a variety of bioinformatics approaches including 
receptor topology and conservation of synteny. They identified only two Class I 
receptors, one resembling the GP-130 receptor, and the other with similarity to the CLF-
3 receptor. No orthologues of the LEPR were identified. This suggests that 
diversification of the Class I cytokine receptor family, including the appearance of the 
leptin receptor, occurred after the divergence of urochordates and vertebrates. The fact 
that no leptin-like sequences have been reported in invertebrates, including the Chinese 




1.4 Leptin in non-mammalian vertebrates - birds 
 
The first evidence to suggest that the leptin gene has been conserved in non-mammalian 
vertebrates was based on Southern hybridization of a mouse leptin probe to genomic 
DNA from chicken and eels (Zhang et al., 1994). Afterwards, two independent 
laboratories reported the cloning of a chicken leptin cDNA, using primers based on the 
mouse leptin sequence (Taouis et al., 1998, Ashwell et al., 1999) and indicated that the 
main site of leptin gene expression was in the liver, which is the major site of fat 
synthesis in birds. The cDNA identified shares 97% identity with mouse leptin at the 
amino acid level in both cases. This percentage is greater than for sequence identities 
found between mammalian leptin sequences (Table 1). This high level of sequence 
similarity is not repeated for leptin genes between mammalian species (Doyon et al., 
2001). The close similarity between mouse and chicken leptin induces doubt concerning 
the nature and origin of this sequence. Several independent laboratories (Friedman-
Einat et al., 1999, Dunn et al., 2001) have argued the improbability of the existence in 
nature of the published chicken leptin cDNA sequence. This evidence is outlined below. 
 
1.4.1 Evidence against the existence of the published chicken leptin cDNA 
sequences  
 
A basic problem has been the inability of several independent laboratories to repeat the 
amplification with primers and conditions specified by Taouis et al., (1998), and using 
other appropriate primers, of chicken leptin cDNA (Friedman-Einat et al. 1999; Pitel et 
al., 2000; Amills et al., 2003, Carre et al., 2006). For example, Friedman-Einat et al. 
performed PCR using fourteen primers based on the mouse leptin sequence. No PCR 
products sharing close similarity to the mouse leptin sequence were obtained from any 
avian templates.  
 
A second piece of evidence comes from attempts to hybridize mouse leptin probes to 
chicken mRNA or genomic DNA using Northern and Southern blotting. If the sequence 
similarity between the mouse and chicken genes is as high as suggested, they should 
hybridize easily. However, no signal was obtained when Northern hybridization was 
performed using a mouse leptin probe against chicken fat and liver mRNA (Friedman-
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Einat et al., 1999), whereas a strong signal was obtained from control mouse fat total 
RNA.  
 
Southern hybridization under low stringency washing conditions showed a weak 
hybridization signal of chicken genomic DNA to a mouse leptin probe (Friedman-Einat 
et al., 1999, Dunn et al., 2001). This supports the suggestion of Zhang et al. (1994) that 
a leptin gene orthologue may be present in the chicken. However, the hybridization 
signal between chicken and mouse DNA was lost after washing under higher stringency 
conditions, while a signal between the mouse probe and sheep DNA (which shares 83% 
sequence identity with the mouse) remained. This therefore suggests that the sequence 
similarity between the chicken and the mouse leptin genes is not as high as reported 
(Taouis et al., 1998).  
 
A third piece of evidence inducing doubt about the nature and origin of the published 
chicken leptin cDNA sequences comes from consideration of the high sequence identity 
between the mouse and chicken leptin genes. The improbability that the high amino 
acid sequence identity of 95 % between the mouse and chicken sequences would have 
arisen during molecular evolution was indicated by analysis of the rate of synonymous 
substitutions between these genes (Dunn et al., 2001). The frequency of synonymous 
substitutions (nucleotide changes in codons that do not change the encoded amino 
acids) was calculated between randomly selected mouse and chicken genes and the 
distribution was compared statistically with the minimal number of synonymous 
substitutions present between the mouse and chicken leptin sequences. The results 
showed that the chicken leptin sequence lies at the extreme of the estimated distribution 
of synonymous substitutions, with a statistical probability of less than 1 in 1 million 





Figure 7 Distribution of values for the rate of synonymous substitutions for 20 
randomly-selected genes and for leptin. Using randomly generated numbers 20 genes 
which had mouse homologues in GenbEmbl and contained alignable protein coding 
regions were selected from a list of 1073 chicken genes. The chicken sequence 
accession number is listed followed by the gene name and the mouse sequence 
accession number; 1) D45416 Neuropilin D50086, 2) L13234 Jun-binding protein. 
X75312, 3) AF131057 Substance P Receptor X62934, 4) X89507 AMPA Receptor 
AB022913 5) M74057 Growth Hormone Receptor M33324 6) U37273 CWH-2 Y08222 
7) AF041799 Insulin Receptor-related tyrosine kinase AF056187 8) M26810 NGF 
V00836 9) AF082666 Interleukin receptor 10-2 U53696 10) X65458 Stathmin X94915 
11) X04810 Carbonic anhydrase II K00811 12) L21719 C-eyk L11625 13) AF036942 
Photoreceptor guanylate cyclase I L41933 14) AF085248 Calmodulin X14836 15) 
U20216 Inward Rectifying K channel AF021136 16) L12695 En-1 Y00201 17) U62143 
Hoxb-1 X53063 18) AF071026 Truncated testis-specific box1 BPRCR X73372 19) 
L18784 TGF-b type II receptor D32072 20) AB002410 17- hydroxy steroid 
dehydrogenase X89627 21) AF012727 Leptin U18812 (Dunn et al., 2001) 
 
The rate of synonymous substitutions has been used to construct phylogenetic trees for 
leptin and for prolactin (another cytokine hormone) to show the relationship between 
members of gene families and the taxonomic relationship between vertebrate classes. 
The tree for prolactin indicates early divergence for the avian and mammalian lineages 
following the accepted model for vertebrate evolution. However, the tree derived from 
leptin shows divergence of birds from rodents in the relatively recent past. This research 
suggests that, contrary to expectation, there is higher sequence identity between chicken 
and mouse leptin sequences than between the mouse and other mammals, further 





Figure 8 Phylogenetic trees constructed using synonomous substitutions for leptin and 
prolactin in marsupial, sheep, human, chicken and mouse sequences. Comparisons were 
produced in the same way as for Figure 7. The rate of synonomous substitution was 
determined with multiple alignments of human, sheep, mouse, marsupial and chicken 
genes. Sequences used were for prolactin; human (V00566), sheep (M27057), marsupial 
(AF067726), mouse (NM011164), and chicken (J04614) and for leptin; human 
(NM000230), sheep (U84247), marsupial (AF159713), mouse (U18812), and chicken 
(AF012727). The regions aligned were equivalent to base 120-557 of GenEmbl leptin 
sequence U18812 and 118-687 of GenEmbl prolactin sequence J04614 (Dunn et al., 
2001). 
 
A key fourth piece of evidence against the existence of the published chicken leptin 
cDNAs is that no evidence has been provided that the sequence is present in avian 
genomes. Thus, the available information has been based solely on identification of 
cDNA sequences and no evidence of a genomic sequence corresponding to the cDNA, 
including intronic sequence, has been shown. The sequencing of the chicken genome in 
2004 (International Chicken Genome Sequencing Consortium, 2004) and zebra finch 
genome in 2010 (Warren et al. 2010)  have not helped to resolve the issue because the 
published cDNA sequences cannot be aligned to them, and the leptin gene is missing 
from the chromosomal region where it would be expected to be located on the basis of 
conservation of synteny (Pitel et al., 2010). Additionally, there is no evidence for the 
published chicken leptin cDNA sequences in the available chicken EST clones, of 
which there are approximately 0.5 million from a variety of tissues and developmental 




Taken together, this evidence based on experimental and evolutionary analysis reveals 
how unlikely it is that the published chicken leptin sequence exists in the chicken 
genome. The best explanation for the published cDNA sequences is that they represent 
cloning artefacts.  
 
Species Chicken Mouse Human 
Mouse 94.6 100 83.2 
Rat 91.6 96.4 82.0 
Human 79.0 83.2 100 
Cow 78.4 83.2 84.4 
Pig 77.8 82.0 85.0 
Rhesus monkey 77.2 81.4 89.8 
Cat 76.0 80.8 84.4 
Dog 73.1 77.8 80.2 
Dunnart 64.1 67.1 67.7 
 
Table 1 Percentage of amino acid identity for known leptin sequences of chicken, 
mouse and human compared with mammalian sequences (Doyon et al., 2001). 
 
1.4.2 The avian leptin receptor 
 
Although the evidence for a chicken leptin gene is uncertain, there is evidence that a 
leptin-like signaling system is present in birds because receptor sequences have been 
cloned in the chicken (chLEPR) and turkey that share greater than 90% sequence 
identity at both the nucleotide and amino acid level (Horev et al., 2000; Ohkubo et al., 
2000; Richards and Poch, 2003). The chicken and turkey LEPR gene (long form) 
encodes a protein of 1147 amino acids that has features similar to other LEPRs 
including: a signal peptide, a single transmembrane domain, and specific conserved 
motifs defining putative leptin-binding and signal transduction regions of the protein. 
The identity between chicken and mouse LEPRs is 60%, indicating a relatively low 
similarity (Horev et al., 2000). Sequences among the mammalian LEPR genes show a 
much higher similarity; 80–92% identical nucleotides, 74–91% identical amino acids. 
This level of sequence similarity is consistent with the estimated evolutionary 
divergence time of about 300 million years between birds and mammals (Ohkubo et al., 
2000).  It also provides further evidence against the existence of the published chicken 
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leptin sequences because, as the leptin sequence identity is so close between the chicken 
and mammals, a greater sequence similarity between chicken and mammalian leptin 
receptors would have been expected. 
 
Sequence analysis provides evidence that the cloned avian receptors show sequence 
conservation of motifs with mammalian LEPRs. Thus far, comparisons between the 
predicted protein sequences have shown a conservation of key LEPR motifs, predicted 
exon boundaries and essential tyrosine residues. Exons 9 and 10, involved in ligand 
binding, are conserved in the avian receptor, with a sequence identity in this region 
between chicken and human of 75% (Ohkubo et al., 2000). 
  
The characterized chLEPR consists of the putative signal peptide, a single 
transmembrane domain and the conserved box 1, 2 and 3 motifs in the cytoplasmic 
region, strongly suggestive of functional conservation. In the extracellular region of 
chLEPR the Trp-Ser-X-Trp-Ser motif implicated in ligand binding and signal 
transduction of the cytokine receptor gene family is present. This motif is conserved in 
terms of sequence and positions. Similarly conserved are the box 1 motif and the 
tyrosine Y-986, Y-1079, and Y-1141, implicated in the JAK/STAT signaling of the 
mammalian LEPR genes (Tartaglia et al., 1995). In the predicted transmembrane 
domain, all amino acid changes are conservative, thereby keeping its hydrophobic 
characteristic.  
 
In 2000, the leptin receptor gene was mapped to the chicken chromosome 8 in the 
equivalent syntenic position to the leptin receptor in the human genome. This finding 
provides additional evidence, along with the preservation of sequence motifs, that the 
chicken gene cloned is a leptin receptor (Dunn et al., 2000). High levels of chLEPR 
mRNA expression were observed in ovary and brain and this pattern of mRNA 
expression is similar to the mammalian LEPR genes (Horev et al., 2000, Richards and 
Poch, 2003). The expression of leptin receptor mRNA was identified in granulose and 
theca cells in the ovary (Cassy et al., 2004). This finding suggests that the level of 
expression of the leptin receptor regulates the action of its ligand in the ovary. 
 
If the leptin signalling system has been conserved between birds and mammals, 
conservation of the mammalian pattern of splice variation in the receptor might be 
expected in the avian genes. Northern analysis revealed two transcripts of the LEPR 
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mRNA, about 5 and 7 kb (higher intensity) in size (Horev et al., 2000). This study 
suggested that two splicing variants are present in the chicken, with higher expression 
of the long form of the chLEPR. However, another study (Ohkubo et al., 2000) only 
found evidence for a single transcript. More recently, (Liu et al., 2007), an alternatively 
spliced short form of the chLEPR was identified. Alternative splicing of the chLEPR 
has been predicted on the basis of sequence conservation between birds and mammals at 
the junction between exons 19 and 20 (Richards and Poch, 2003). The results suggest 
that the short form of chLEPR is not directly comparable with the mammalian LEPR 
short form, in that its expression appears to be lower and could not be detected in the 
choroid plexus, a major site of expression of the short form of the LEPR in mammals. 
The expression of the chLEPR short form was highest in the pituitary gland and ovary 
(Liu et al., 2007), but it remains to be determined whether the mRNA identified is 
translated and has any functional significance. 
 
 
Figure 9 A scheme of turkey and mammalian LEPRs (long form and other splice 
variants that have been identified for the mammalian receptor); positioning of conserved 





1.4.3 Effects of leptin administration 
 
To investigate different function of leptin in birds, injections of recombinant mouse or 
chicken (97% identical to mouse) leptin have been performed. Feeding behaviour in 
domestic chicks was studied after intracerebroventricular administration of mouse leptin 
(Bungo et al., 1999). Central administration of mouse leptin did not influence food 
intake relative to saline controls in the time periods examined. The effect does not agree 
with the result of leptin injection in mammals, where leptin rapidly lowers food intake 
(Mistry et al., 1997). This study suggests that either mouse leptin does not bind to the 
chicken leptin receptor or that leptin may be absent in the chicken. This is evidence 
against the existence of the published chicken leptin cDNA sequences. It seems unlikely 
that amino acid sequence of chicken leptin shares with mouse 97% identity if there are 
differences in effect of administration between mammalian and avian species. Later 
studies demonstrated an inhibitory effect of mouse or chicken leptin on food intake in 
birds when administered centrally or peripherally (Denbow et al., 2000; Dridi et al., 
2005). 
 
Previous research in mammals has shown that leptin is involved in regulating the 
secretion and expression of several neurotransmitters and neuropeptides expressed in 
the hypothalamus. A study in chickens indicated some similarity with mammalian 
systems in that reduced food intake induced by central injection of recombinant chicken 
leptin was associated with reduced hypothalamic gene expression of neuropeptide Y 
(NPY) an orexigenic neuropeptide that stimulates appetite and inhibit energy 
expenditure (Dridi et al., 2005).  An inhibitory effect of leptin on NPY neurones, which 
express the leptin receptor, is well established (Schwartz et al., 1996).However leptin 
administration did not have an effect on other hypothalamic neuropeptides that have 
been demonstrated to be responsive to leptin in mammals such as agouti-related protein 
(AgRP – an orexigenic/anabolic neuropeptide) and proopiomelanocortin (POMC) and 
corticotropin (CRH) (anorexigenic/ catabolic neuropeptides). This finding does not 
correlate with the results obtained in mammals. AgRP, that stimulates food intake, is a 
negative regulator of leptin action and leptin decreases hypothalamic AgRP production 
(Mizuno et al., 1998, Ebihara et al., 1999). POMC and CRH are anorexigenic 
hormones, which are involved in inhibition of appetite and stimulation of energy 
expenditure and treatment mice with leptin stimulates hypothalamic POMC and CRH 
mRNA (Mizuno et al., 1998). The contrast between the mammalian and avian findings 
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is consistent with the possibility that the sequence similarity of mouse and chicken 
leptins with a native chicken leptin is not close. 
  
Other findings from studies of leptin administration demonstrate the existence of a 
leptin signalling pathway in birds. For example, a stimulatory effect of mouse leptin has 
been found on cell proliferation and protein synthesis in muscle and liver cells from 
chicken embryos (Lamosova and Zeman, 2001) and mouse leptin administration during 
embryonic development of birds revealed permanent changes of endocrine and 
metabolic parameters regulating growth and development (Lamosova et al., 2003). 
Thus, leptin administration to eggs affected thyroid hormone (TH) levels that regulate 
growth and development and increase metabolism. Treated chickens had higher body 
weight compared to the control group consistent with the observed alterations in thyroid 
status. The most prominent changes in triiodothyronine (T3), and thyroxine (T4) 
appeared immediately after hatching and before sexual maturity. The finding suggested 
that leptin may act as a general signal of low energy status to neuroendocrine systems in 
birds. Previous studies on administration of leptin to mice have revealed also changes of 
the thyroid axes (Ahima et al. 1996).  
 
The possibility that leptin may act as a signal of body fat stores in birds is also 
suggested by the effect of leptin injections  on prepubertal development and the timing 
of reproductive maturity in chickens (Lamosova et al., 2003, Paczoska-Eliasiewicz et 
al., 2006). Leptin treatment during embryonic development precipitated the onset of 
puberty in comparison to controls, evidenced by age at first oviposition and increased 
testicular weight in males. Injection of mouse leptin shows in males higher weight of 
the testes and in females earlier sexual maturnity than the controls (Lamosova et al., 
2003). Similarly, treatment of prepubertal female chickens with systemic injections of 
mouse leptin advanced the onset of puberty (laying of the first egg) and abolished the 
delay caused by food restriction. Analysis of the ovaries revealed that leptin injections 
advanced follicular development, particularly in birds fed ad libitum, and significantly 
reduced follicular apoptosis both in full-fed and feed-restricted birds. Moreover, the 
increases of luteinizing hormone, estradiol and progesterone in blood plasma were also 
advanced by leptin treatment (Paczoska-Eliasiewicz et al., 2006). These findings agree 




In addition to effects on energy balance and reproduction, administration of mammalian 
leptin to birds has also been observed to influence the immune system. For example, 
positive effects on T-cell proliferation in birds have been revealed during leptin 
injection with mitogen used to stimulate lymphocytes and assess immune function 
(concavalin A, phytohemagglutinin). The response to mitogens was greater in leptin 
treated birds during the leptin administration (Lõhmus et al., 2004). The study provides 
that leptin enhances mitogen stimulated T-cell proliferation in birds. The results 
correspond with previous reports on mammals (Lord et al., 1998), suggesting that leptin 
is an important modulator of the immune response regarding the T-cell response.  
 
Overall, studies involving administration of recombinant mammalian leptin in birds 
show some similarity with mammalian systems. These findings suggest that a leptin-
like signaling system is present in birds, however the differences in results suggest that 
the sequence similarity between the chicken and the mouse leptin genes is not as high as 
reported (Taouis et al., 1998).  
 
1.4.4 Leptin receptor signalling 
 
To assess the functionality of the chicken receptor (chLEPR), leptin bioassays based on 
the activation of chLEPR in cultured cells, were performed. The experiments showed 
that chickens response to exogenous administration of human and frog leptins in vitro 
and the chLEPR can mediate the leptin signal (Hen et al., 2008; Adachi et al., 2008). 
Exogenous leptin binds specifically to the chLEPR and activates luciferase which leads 
to phosphorylation of signal transducer, activators of transcription 3 (STAT3) and Janus 
kinase-2 (JAK-2) (Adachi et al., 2008). These findings indicate that the LEPR in 
chicken tissues is functional and capable of binding leptin, leading to activation of the 
JAK-STAT signal transduction pathway and inducing physiological processes (Hen et 
al., 2008; Adachi et al., 2008). However, although the bioassay was able to detect leptin 
in human serum samples, no signalling activity was detected in samples from fat and 
lean chickens, or from turkeys (Hen et al. 2008).  A similar lack of leptin bioactivity 
was shown in blood samples collected from wild Adelie penguins and bar-tailed 
godwits (Yosefi et al., 2010).  These species show natural seasonal fattening cycles 
linked to incubation and migration and blood samples from these species were taken 
and compared for leptin signalling activity using the chicken receptor assay with human 
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samples taken over a similar range of body fat content. Again, the human samples 
activated the receptor but the bird samples did not. The data from the bioassays suggest 
that leptin is either absent in birds, or circulates in the blood at much lower levels than it 
does in mammals. 
 
Overall the available information on leptin in birds supports the existence of a leptin 
signalling system but the identity of the ligand remains uncertain: it is possible that the 
receptor has evolved to interact with another ligand, or may be constitutively active. If 
leptin is present, it may play a paracrine, rather than endocrine role. The possible 
absence of leptin in birds may be related to the different way, that birds regulate glucose 
metabolism, connected with the evolution of flight (Pitel et al., 2010).  
 
1.5 Leptin in non-mammalian vertebrates – reptiles 
 
Very recent studies have provided the evidence for the existence of leptin-like 
molecules in reptiles. Evidence for the presence of leptin-like proteins has been 
presented for two species of reptiles; Sceloporus undulates and Podarcis sicula 
(Niewiarowski et al., 2000, Paolucci et al., 2001; Paolucci et al., 2006; Sciarrillo et al., 
2005, Spanovich et al., 2005).  
 
1.5.1 Detection of leptin-like immunoreactivity 
 
The evidence for the presence of leptin protein in reptiles was provided by 
immunolabelling of tissues from two lizards (Newiarowski et al., 2000, Paolucci et al., 
2001). The presence of the hormone was detected using anti-mouse leptin antibodies. 
These recognized bands of the appropriate size for leptin (16kDa) in the brain of 
Sceloporus undulates (Niewiarowski et al., 2000) and in the plasma, liver and fat bodies 
of the female of Podarcis sicula (Paolucci et al., 2001). It was suggested that the 
presence of leptin in brain was caused by binding of hormone by its receptor rather than 
leptin being synthesized in the brain itself. Leptin levels in plasma, liver and fat bodies 
fluctuated during the reproductive cycle, in a way consistent with its possible role in 
reproduction (Paolucci et al., 2001). The amount of fat increases in this lizard during the 
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winter months and decreases as soon as sexual activity resumes at the beginning of the 
spring (Paolucci et al., 2001). It is correlated to the fact that reproduction is related with 
energy metabolism and requires sufficient nutrition. These findings agree with studies 
in mammals where the first evidence to suggest that leptin is involved in reproduction 
was based on the observation that obese (ob/ob and db/db) mice, later found to be 
lacking functional leptin or leptin receptor, are unable to undergo sexual maturation, and 
are infertile (Swerdloff et al., 1976). 
 
1.5.2 Identification of leptin-like genes 
 
There is evidence from analysis of the Anolis carolinensis lizard genome 
(http://genome.ucsc.edu/cgi-bin/hgGateway) for a leptin-like sequence that shares 
approximately 44% and 53% amino acid sequence identity with human and 
mouse leptins, respectively. Importantly, the gene is present in the syntenic 
chromosomal position predicted for leptin (Boswell 2011). However, the gene remains 
to be characterised. 
 
1.5.3 Leptin receptor 
 
LEPR-like immunoreactivity was detected in both the A and B cells of the endocrine 
pancreas of Podarcis sicula. This was the first report of LEPR immunoreactivity on A 
cells (Paolucci et al., 2006). This supports the observation of increased circulating 
insulin and glucagon concentrations after leptin administration, indicating a direct effect 
of leptin on pancreactic cells (Paolucci et al., 2006). This study supported the 
involvement of leptin in glucose metabolism in reptiles, although regulation of this 
system appears quite different from mammals (Paolucci et al., 2006).  
 
LEPR-like immunoreactity was also found in the thyroid gland (Sciarrillo et al., 2005) 






1.5.4 Effects of leptin administration 
 
To investigate the function of leptin in reptiles, injections of recombinant murine leptin 
have been performed. Systemic injection of recombinant murine leptin in lizards 
(Sceloporus undulatus) produces phenotypic effects similar to those observed when 
leptin injections are given to mice, such as higher body temperature and reduction of 
food intake (Niewiarowski et al., 2000). However, administration of leptin did not cause 
a decrease in body mass relative to saline controls in the time periods examined. The 
effect does not agree with the result of leptin injection in mammals, where leptin rapidly 
lowers food intake and reduce body mass (Mistry et al., 1997). It is possible that leptin 
has different functions in reptiles and mammals and this may be related to the 
differences in energy metabolism between endotherms and ectotherms (Niewiarowski et 
al., 2000). 
 
Data on the effect of leptin treatment on circulating levels of insulin and glucagon show 
significant increases in the concentrations of both hormones (Paolucci et al., 2006). 
These findings do not agree with studies in mammals, where leptin plays a role as an 
antiobesity hormone and inhibits insulin secretion (Kulkarni et al., 1997; Kieffer and 
Habener, 2000). This study shows also that leptin is involved in glucose metabolism as 
it is in mammals (Mizuno et al., 1996). However, the effects of leptin administration 
suggest that leptin regulation of glucose metabolism is different from mammals and 
leptin may have a wider range of functions in reptiles (Paolucci et al., 2006). 
 
Leptin administration stimulates the thyroid gland in reptiles, increasing levels of 
circulating thyroid hormones (T3 and T4) that regulate growth and development and 
raise metabolism (Sciarrillo et al., 2005). Previous studies on administration of leptin to 
mice have also revealed effects on the thyroid axes (Ahima et al. 1996). In addition, 
administration of leptin in the lizard (Podarcis sicula) increased sex steroid 
concentrations and and stimulated the epididymis epithelium (Putti et al., 2009). 
Moreover, leptin injections delay a testis regression (Putti et al., 2009), which normally 
takes place in summer when lizards do not respond to hormonal and environmental 
stimuli (Angelini and Botte, 1992). These findings suggest that leptin is involved in 
testicular function and reproduction in reptiles, in agreement with mammalian studies 




Overall, the evidence of the presence of leptin signalling proteins in reptiles, suggests 
that leptin plays a regulatory role in the energy metabolism of these ectothermic 
vertebrates (Niewiarowski et al., 2000). 
 
1.6 Leptin in non-mammalian vertebrates - fish 
 
The first evidence to suggest that the leptin gene has been conserved in fish was based 
on Southern hybridization of a mouse leptin probe to genomic DNA from eels (Zhang et 
al., 1994). As discussed below more recent studies have provided further evidence for 
the existence of leptin-like molecules in fish. 
  
1.6.1 Detection of leptin-like immunoreactivity 
 
Later evidence for leptin’s expression in fish was provided by immunolabelling of 
tissues from fish (Johnson et al., 2000; Pfundt et al., 2009; Gambardella et al., 2010; 
Russo et al., 2010). The presence of the hormone was detected using different 
polyclonal antibodies against mammalian leptin. Mammalian anti-leptin antibodies 
recognized bands of the appropriate size for leptin (16kDa) on Western blots of protein 
extracts of blood, brain, heart, stomach and liver of green sunfish (Lepomis cyanellus), 
bluegill sunfish (Lepomis macrochirus), largemouth bass (Micropterus salmoides), 
white crappie (Pomonix annularis), channel catfish (Ictalurus punctatus), rainbow trout 
(Oncorhynchus mykiss) (Johnson et al., 2000). It was suggested that the presence of 
leptin in the brain was caused by binding of hormone by its receptor rather than leptin 
being synthesised in the brain itself (Johnson et al., 2000). In addition, 
immunohistochemical analyses have shown existence of leptin in the gastrointestinal 
tract of sea bass (Dicentrarchus labrax), goldfish (Carassius auratus) (Russo et al., 
2010) and catshark (Scyliorhinus canicula) (Gambardella et al., 2010). This finding 
agrees with mammalian studies, where the stomach is a common site of leptin 





1.6.2 Identification of leptin-like genes 
 
The next piece of evidence to suggest that a leptin gene is present in fish was provided 
by the availability of whole-genome sequences in fish. Leptin-like genes were identified 
from investigations of the genomic synteny around mammalian leptin genes (Figure 
10). For example, recently, leptin-like genes have been identified from pufferfish 
(Takifugu rubripes), the spotted green pufferfish (Tetraodon nigrovirides), medaka 
(Oryzias latipes) (Kurokawa et al., 2005), common carp (Cyprinus carpio) (Huising et 
al., 2006a), zebrafish (Danio rerio) (Gorrisen et al., 2009), Atlantic salmon (Salmo 
salar) (Ronnestad et al., 2010), arctic charr (Salvelinus alpinus) (Froiland et al., 2010) 
and grass (Ctenopharyngodon idellus) and silver carp (Hypophthalmichthys molitrix) 
(Li et al., 2010). The predicted fish leptin proteins show less than 25% amino acid 
sequence identity with mammalian leptins and the similarity between pufferfish and 
carp leptins is only slightly higher (Huising et al., 2006a). This considerable sequence 
dissimilarity between fish species is explained by the large evolutionary distance 
between cyprinids and pufferfishes, which diverged approximately 300 million years 
ago. Despite the low amino acid sequence identity, there is evidence that fish leptins are 
in fact orthologs of mammalian leptins. Firstly, they show conservation of gene 
structure, consisting of three exons, as in mammals, and the two coding exons are very 
similar in length to the corresponding exons of the human and mouse leptin genes 
(Kurokawa et al., 2005; Huising et al., 2006a) Secondly, in fish leptins, there is 
evidence for conservation of secondary and tertiary structure. Two conserved cysteine 
residues can be identified that together form a disulphide bridge, a conserved feature 
with mammalian leptins, and  models of fish leptins, based on the crystal structure of 
human leptin confirm the characteristic four-helix bundle topology of class-I helical 
cytokines (Kurokawa et al., 2005; Huising et al., 2006a). Thirdly, the fish leptins cluster 
with mammalian leptins in phylogenetic analysis, supported by high bootstrap values 
(Gorrisen et al., 2009) (Fig.10). This suggests that they may possess specific leptin 





Figure 10 Peptide phylogenetic relationships of leptin and growth hormone (GH) using 
the neighbor-joining method in Clustal W and MEGA3. Numbers at nodes indicate the 
bootstrap value (%), obtained for 1000 replicates. GenBank Accession Nos. LEP: 
mouse, AAI25246; X. Laevis, NP_001089183; X. tropicalis, scafolld 11 (JGI ver. 4.1); 
axolotl, CO792338. GH: human, CAA23779 (Kurokawa et al., 2009). 
 
 In contrast to pufferfish and arctic charr, duplicate leptin genes have been identified in 
carp (Huising et al., 2006a; Li et al., 2010), zebrafish, medaka (Gorrisen et al., 2009) 
and Atlantic salmon (Ronnestad et al., 2010). The presence of duplicate leptin genes in 
these fishes suggests that duplicate leptin genes are a common feature of teleostean 
fishes. The duplicate zebrafish leptin genes, coding for leptin-a and leptin-b, share only 
24% amino acid identity with each other and only 18% with human leptin. That both 
leptin-a and leptin-b are orthologs of human LEP and paralogs derived from whole-
genome duplication early in the teleost lineage (Gorissen et al., 2009). The duplicate 
carp leptins have different coding regions, 5’ and 3’ untranslated regions, and introns. 
Moreover the sizes of the introns within the genomic sequences are different. These 
findings suggest that both carp leptin sequences are derived from separate genes rather 
than from the same gene through alternative splicing. Both carp leptin genes encode 171 
amino acid leptin proteins that share 82 % amino acid identity (Huising et al., 2006a). 
Their high level of amino acid similarity suggests that both carp leptin genes are the 
likely result of a recent gene duplication event, possibly the recent tetraploidisation of 
the carp genome that occurred less than 16 million years ago (Huising et al., 2006a). 
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The duplicate salmon leptins show 71.6% similarity to each other with 22.4% (Lep-A1, 
171aa) and 24.1% (Lep-A2, 175aa) identity to human leptin. The highest expression 
level of Lep-A1 was found in the brain, white muscle, liver, and ovaries. Lep-A2 had a 
lower expression than Lep-A1 in most tissues except for the stomach and mid-gut and 
kidney (Ronnestad et al., 2010). These results suggest that Lep-A1 is important in 
energy metabolism what agrees with mammalian model, whereas Lep-A2 may play a 
role in the digestive tract and liver (Ronnestad et al., 2010). 
 
 
Figure 11 Comparison of leptin gene characterization between human and puffer (A) 
Gene arrangement and the cDNA structure of the leptin gene. Arrows indicate the 
direction of transcription of the genes. Shaded areas indicate open reading frame. 
GenBank accession nos.: Pax4, NM 006193; SND1, NM 014390; NAG8, NP 055226; 
LRRC4, NM 022143; RBM28, NP 060547; LOC401339, XP 379517; IMPDH1, NP 
000874. (B) Ribbon diagram showing the tertiary structure of human and puffer leptin. 
Secondary and tertiary protein structures were modeled using the ProModII program at 
the SWISS-MODEL automated protein modeling server, based upon human leptin 
(1AX8.pdb) Protein Data Bank structure file (Kurokawa et al., 2005). 
 
In addition, it has been demonstrated by dissection of embryo and larvae of Atlantic 
salmon, that leptin is supplied as a maternal transcript (Moen et al., 2010). Moreover, in 
larvae the highest expression of leptin has been found in the head and the large increase 




1.6.3 Leptin receptor 
 
A full-length LEPR gene has been identified from marine medaka (Oryzias melastigma) 
(Wong et al., 2007), pufferfish (Takifugu rubripes) (Kurokawa et al., 2008), Japanese 
medaka (Oryzias latipes) (Kurokawa and Murashita, 2009) and Atlantic salmon (Salmo 
salar) (Ronnestad et al., 2010). The predicted genes consist of 3348bp (21exons) 
(pufferfish; GenBank Accession No.AB385663), 3225bp (20 exons) (Japanese medaka; 
GenBank Accession No.AB457590) and 3441bp (Atlantic salmon; GenBank Accession 
No. AB489201), and encode 1116, 1074 and 1146 amino acids, respectively. The fish 
LEPR genes share less than 25% identity to mammalian leptin receptors (Figure 12). 
Sequences among the fish LEPR genes show 82-32.5% similarity at amino acid level. 
The amino acid sequences of Japanese medaka LEPR shares 81.8% and 47.4% 
identities with the LEPR of marine medaka and pufferfish, respectively. The identity 
between pufferfish and medaka is 46% (Kurokawa et al., 2008). The amino acid 
sequence of salmon LEPR has 32.5–42.6% identity with other fish LEPRs (Ronnestad 
et al., 2010). Despite the low amino acid sequence identity the fish LEPR genes contain 
all functionally important domains conserved among vertebrate LEPRs: three 
fibronectin type III (FN III) domains, the immunoglobulin (Ig) C2-like domain and a 
pair of repeated tryptophan/serine motifs (WSXWS) at an extracellular segment, and 
two JAK2-binding motif boxes and a STAT binding domain at an intracellular segment 
(Kurokawa and Murashita, 2009; Ronnestad et al., 2010). It is been demonstrated that 
there is five different LEPR isoforms presented in fish, which have different 3’ ends of 
mRNA sequence (Ronnestad et al., 2010). Only one isoform is functional, containing all 
the important signalling domains (Ronnestad et al., 2010). In the crucian carp (Cao et 
al., 2011) and marine medaka (Wong et al., 2007), differential changes in expression of 
the long and secreted isoforms were reported in response to fasting and hypoxia, 
suggesting that short LEPR isoforms have a physiological role in teleost fish. In 
addition, hypoxia treatment induced expression of the short and long LEPR isoform in 
the gill, liver and heart (Cao et al., 2011; Wong et al., 2007) suggesting that leptin 
signaling pathway may play an important function in acclimation to hypoxia. 
 
Expression of the LEPR in fishes was widespread, with the highest expression detected 
in the pituitary gland and ovary, moderate expression has been shown in brain, eye, 
heart, kidney, gill, skin, visceral adipose tissue, red muscle, liver and testis (Kurokawa 
et al., 2008; Ronnestad et al., 2010). These findings agree with pattern of mRNA 
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Figure 12 Comparison of the amino acid sequence of the putative leptin-binding region 
of LEPRs. Deletions are indicated by dashes and shaded areas indicate residues shared 
by >60% of all sequences. GenBank Accession Nos.: human, AAA93015; chicken, 
BAA94292; X. tropicalis, NP001037866; O. melastigma, ABC86922; mLEPR, 
AB457590 (Kurokawa and Murashita 2009). 
 
1.6.4 Effects of leptin administration 
 
To assess the role of leptin on food intake regulation in coho salmon (Oncorhynchus 
kisutch) (Baker et al., 2000), green sunfish (Lepomis cyanellus) (Londraville et al., 
2002), goldfish (Carassius auratus) (Volkoff et al., 2003), and carp (Cyprinus carpio) 
(Huising et al., 2006), the injection of mammalian leptin has been performed. The 
results which have been obtained are unexpected compared with information about 
leptin in mammals. No clear effects have been found of human leptin on parameters 
such as growth, energy stores, gonad weight, and level of insulin, growth hormone or 
thyroxine (Baker et al., 2000, Londraville et al., 2002).  
 
A number of reasons have been put forward to explain why injections of mammalian 
leptin in fish do not produce similar effects to those in mammals. Firstly, as discussed 
above, the sequence similarity between fish and mammal leptins appears to be low. 
Thus, mammalian leptins may not interact appropriately with the fish receptors. 
Secondly, it is possible that fish would be more responsive to mammalian leptin under 
different conditions, such as higher temperature, different seasons or developmental 
stages. Thirdly, it is possible that leptin has different functions in fish and mammals and 
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this may be related to the differences in energy metabolism between endotherms and 
ectotherms, where leptin’s action may be slower when body temperature is lower 
(Londraville et al., 2002, Huising et al., 2006). 
 
However, murine leptin injections increase intracellular fatty acid-binding protein 
(FABP) in green sunfish, which transports fatty acids across the cytoplasm to the site of 
their oxidation. The results provide evidence for a possible role of leptin in regulating 
lipid metabolism in fish, and that fish have receptors that recognize mammalian leptin 
(Londraville et al., 2002).  
 
Unlike the situation with other fish species, leptin injection in goldfish (Carassius 
auratus) causes a reduction of food intake, in line with what has been reported in 
mammals showing that treatment with recombinant leptin increases energy expenditure 
and decreases food intake, body weight and body fat stores (Ashima et al., 2000). 
Moreover, fish co-injected with NPY or orexin A, orexigenic neuropeptides produced in 
the hypothalamus, and leptin had a food intake lower than that fish treated with NPY or 
orexin A alone (Volkoff et al., 2003).  The result suggests an interaction between leptin, 
NPY and orexin A.  This finding correlates with studies on mammals, where during 
fasting, reduced hypothalamic leptin signaling stimulates neuropeptide Y (NPY, which 
stimulates food intake) and inhibits corticotrophin releasing hormone (CRH, an 
inhibitor of food intake) production and release (Schwartz et al., 1996). Furthermore, 
results have been obtained, which suggest that the actions of leptin are mediated by 
cholecystokinin (CCK), which acts as a neurohormone to reduce food intake (Hsiao et 
al., 1983). These findings suggest that leptin plays an important role in the regulation of 
feeding and energy homeostasis in goldfish. It is not clear why the results of 
mammalian leptin injections in goldfish are different from those obtained from other 
species.  
 
As might be expected the injection of recombinant fish leptins produces more bioactive 
effects in fish than mammalian leptins. For example, rainbow trout leptin suppressed 
food intake in rainbow trout (Oncorhynchus mykiss) (Murashita et al., 2008, Aguilar et 
al., 2010) and the same effect has been observed with recombinant carp leptin in grass 
carp (Ctenopharyngodon idellus), however food intake was reduced only on the first 
day after injection (Li et al., 2010). It is been demonstrated that leptin treatment 
decreased NPY mRNA levels in hypothalamus (Aguilar et al., 2010, Li et al., 2010). 
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Moreover, leptin administration increases levels in parameters involved in glucosensing 
(GK, PK and GSase activities; GK expression and glucose; glycogen and DHAP levels) 
(Aguilar et al., 2010). This anorexic effect is similar to that observed in mammals 
(Schwartz et al., 1996) and supports that the neuroendocrine pathways that control 
feeding by leptin are ancient and have been conserved through evolution. 
 
Recombinant salmon leptin administration was performed on Atlantic salmon and 
showed significantly reduced growth rate and increased relative liver size (Murashita et 
al., 2011). This finding agrees with mammalian species, where leptin treatment reduces 
food intake and body weight (Mistry et al., 1997; Wetzler et al., 2004). This effect was 
linked to increased POMC expression (Murashita et al. 2010). These results differ from 
a study on coho salmon (Oncorhynchus kisutch), where human leptin did not cause any 
changes in body weight or any other physiological parameters (Baker et al., 2000). 
 
1.6.5 Changes in leptin expression with nutritional state 
 
The main site of gene expression of fish leptin is in the liver (Kurokawa et al., 2005; 
Huising et al., 2006a), which is different from the situation in mammals where leptin is 
primarily synthesised by adipose tissue (Zhang et al., 1994, Friedman et al., 1998). 
These different findings may be related to the fact that the liver is the major site of 
lipogenesis in non-mammals. This supports the observation that the liver, rather than 
adipose tissue, is one of the main sites of immunoreactive leptin in fish (Johnson et al., 
2000). Leptin gene expression has been studied in carp liver in response to short and 
long-term fasting and refeeding, and in animals fed to satiation (Huising et al., 2007a) 
Leptin expression was not affected by fasting or refeeding, unlike the situation in 
mammals where fasting decreases leptin expression, and refeeding increases it (Saladin 
et al., 1995). NPY gene expression in the hypothalamus, which is increased by 
prolonged fasting in mammals (Clark et al., 1984, Levine et al., 1984) was not changed 
after a 6 week fast, but decreased hypothalamic gene expression of the inhibitory 
feeding peptide genes corticotrophin releasing factor (CRF), pro-opiomelanocortin 
(POMC) and thyrotrophin releasing hormone (TRH) was in line with what has been 
observed in mammals (Legradi et al., 1997). Similar to the effects of fasting, fish that 
were fed to satiation did not show increased leptin expression as might have been 
expected if leptin acts as a long-term satiety signal in fish. In contrast, increased leptin 
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expression was observed after ingestion of a single scheduled meal, providing evidence 
that leptin may act as a short term signal of satiety in carp. This result correlates to the 
postprandial increase in leptin mRNA that is observed in the hours following feeding in 
mice (Saladin et al., 1995) and is in agreement with the observation of an inhibitory 
effect on food intake following injection of recombinant mammalian leptin into the  
goldfish brain (Volkoff et al., 2003). 
 
Long-term food restriction in Atlantic salmon lowered expression of the lep-A1 
transcript in the fat-depositing tissues, visceral adipose tissues and white muscle but 
LEPR mRNA levels in brain, between fish fed reduced and full feeding regimes, did not 
show any difference (Ronnestad et al., 2010). Plasma concentrations of salmon leptin 
were also unaffected (Ronnestad et al., 2010), a result in line with a study on fasted 
rainbow trout in which no correlation was observed between plasma leptin and body 
condition (Kling et al., 2009).  
 
Thus, leptin mRNA expression in fish is altered by changes in food intake, but there is 
limited evidence for involvement of leptin in the long-term regulation of food intake 
and energy metabolism as is the case in mammals (Huising et al., 2006a). These 
findings may be related to the differences in energy metabolism between endotherms 
and ectotherms. Ectotherms do not need to thermoregulate, thus their metabolic 
regulation is more flexible (Huising et al., 2006). For this reason the physiological role 
of leptin in ectotherms may differ quantitatively, if not qualitatively, from its role in 
mammals. 
 
1.7 Leptin in non-mammalian vertebrates - amphibians 
 
Evidence for leptin-like genes in amphibians was presented shortly after the discovery 
of leptin genes in fish. Leptin genes have now been described for four amphibian 
species: the tiger salamander (Ambystoma tigrinum) (Boswell et al., 2006), the axolotl 
(Ambystoma mexicanum) (Boswell et al., 2006), Xenopus tropicalis (Crespi and Denver, 






1.7.1 Identification of leptin-like genes 
 
Leptin-like genes were identified in amphibians as a result of the availability of new 
genomic information in the form of genome sequence and EST libraries. First, a leptin-
like gene found in tiger salamander (Ambystoma tigrinum) and axolotl (Ambystoma 
mexicanum) EST libraries was characterised (Boswell et al., 2006). Later, the coding 
region of the frog (Xenopus laevis and Xenopus tropicalis) leptin gene was reported 
(Crespi and Denver, 2006). Sequence identity between the salamander and Xenopus 
leptin-like genes is 66% at the nucleotide level over the coding sequence (Boswell et al., 
2006).The amphibian leptin genes share less than 35% amino acid identity to 
mammalian leptins. However, several lines of evidence suggest that they represent the 
amphibian orthologues of mammalian leptin genes.  Firstly, the mature peptide contains 
an identical number of amino acids to mammalian leptins (Boswell et al., 2006, Crespi 
and Denver, 2006). Secondly, the reported leptin genes have three exons and two 
introns, with the coding sequence in exons 2 and 3, similar to the genomic structure of 
mammalian leptin genes (Chmurzynska et al., 2003). Thirdly, analysis of the rate of 
non-synonymous substitutions in amphibian, mammal and fish leptin coding sequences 
was performed and followed the consensus pattern of vertebrate evolutionary 
divergence (Figure 13).  Fourthly, comparison between the predicted tertiary structure 
of amphibian and human leptin has shown a conservation of the four-helix bundle 
structure, and the two cysteine residues required for formation of a disulfide bond have 
been conserved in all tetrapod species. Also, conserved leucines were found in 
salamander leptin, residues that are important for the formation of α-helices (Zhang et 
al., 1997; Boswell et al., 2006).  Recombinant Xenopus leptin activated both Xenopus 
and mouse leptin receptors in vitro (Crespi and Denver, 2006). 
 
Different expression patterns were identified in salamanders and Xenopus. In 
salamanders, the highest expression was observed in the skin, with lower expression 
also being seen in the brain, stomach, small intestine, colon, skeletal muscle, tongue, 
and fat body (Boswell et al., 2006). The strongest intensity of the PCR product in the 
frog was detected in the brain and heart, but also in liver, brain, pituitary gland, 
gastrointestinal tract, lungs, kidney, and gonads (Crespi and Denver, 2006). The tissue 
distribution of leptin mRNA is broader in amphibians compared with mammals, where 
expression was primarily observed in fat (Zhang et al., 1994). The wider range of 
expression in amphibians suggests that leptin may have a wider range of functions. In 
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Xenopus leptin is expressed throughout embryogenesis and tadpole development 
(Crespi and Denver, 2006). The expression of leptin mRNA was detected in frog 
oocytes and embryos before feeding stages and adipose tissue formation. The research 
suggests that this hormone may have adipocyte-independent roles in early development 
(Crespi and Denver, 2006). This finding agrees with the reports on mammals where 
widespread expression of leptin and its receptors has been identified in fetal tissues 
(Masuzaki et al. 1997, Hoggard et al. 1997). 
 
Figure 13 Phylogenetic tree constructed using non-synonymous substitutions for 
salamander and mammalian leptins. Trees were created by Growtree (Wisconsin 
Package Version 10.0, Genetics Computer Group, Madison, Wisconsin, USA) with the 
unweighted pair group method using arithmetic averages. Sequences used were human 
(NM_000230), sheep (U84247), fat-tailed dunnart (AF067726), mouse (U18812), dog 
(AB020986), pig (AF052681), Xenopus laevis (AY884210), salmon (BI468126), and 
cow (U43943) (Boswell et al., 2006). 
 
1.7.1 Leptin receptor 
 
A full-length LEPR gene has been reported in Xenopus tropicalis (Crespi and Denver, 
2006). The predicted gene consists of 26 exons and encodes 1,145 amino acids which 
corresponds to the exon structure and size of the receptor in mammals (Tartaglia et al., 
1995). This frog LEPR protein shares only 37% amino acid sequence identity with 
human, however, sequence similarity is greatest in and around the ligand binding 
domain, transmembrane region, and the intracellular C-terminal region. Despite the low 
amino acid sequence identity phylogenetic analysis clearly placed the frog gene within a 
clade of the mammalian leptin receptor gene. A strong expression of LEPR mRNA was 
found in the brain, as is the case in mammals (Tartaglia et al., 1995). Expression of the 
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LEPR in Xenopus was widespread, with the highest expression detected in the pituitary 
gland, and strong levels of expression also observed in the skin, muscle, and testis. 
Lower but detectable levels of expression were found in different visceral organs and 
the ovary (Crespi and Denver, 2006). These findings correspond to the observations of 
widespread tissue distribution of leptin mRNA in Xenopus, indicating a broad range of 
leptin functions in amphibians. 
 
1.7.2 Effects of leptin administration 
 
To investigate the possible function of leptin in amphibians, injections of recombinant 
Xenopus leptin have been performed. Inhibitory effects on appetite were observed after 
central leptin injections in midprometamorphic tadpoles and juvenile frogs (Crespi and 
Denver, 2006). This result shows that leptin has anorectic activity in an ectotherm, 
which correlates with the results of leptin injection in mammals, where leptin rapidly 
lowers food intake (Mistry et al., 1997). Food-deprived frogs injected with leptin lost 
more weight than controls in the time periods examined, suggesting that leptin also 
increases energy expenditure as it does in mammals (Zhang et al., 1994).  Thus, the 
function of leptin as a regulator of food intake and energy balance appears to have 
evolved before the emergence of amniote vertebrates. However no information is 
available on the effects of nutritional state on leptin gene expression in amphibians. 
 
The LEPR is expressed in the hind limb of early prometamorphic tadpoles and lung. 
Injection of recombinant frog leptin induced hind limb growth (Crespi and Denver, 
2006) and lung development (Torday et al., 2009). This finding suggests that leptin may 
have adipocyte-independent roles in early growth. The result agrees with evidence that 
leptin plays a role in mammalian limb (Hoggard et al., 2001) and lung (Torday and 









1.8 The axolotl as a model amphibian 
 
This thesis is focused on studying the biology of leptin in amphibians using the axolotl 
as a model species.  Axolotls are well known neotonic amphibians, native only to Lake 
Xochimilco and Lake Chalco in central Mexico. The animal is a member of the Order 
Caudata which includes newts and salamanders. The closest relative of the axolotl is the 
tiger salamander. The scientific name of the axolotl, Ambystoma mexicanum was given 
by Shaw in 1798 (Shaw, 1798) and was described for the first time in 1828 by Cuvier, 
as the larva of an unknown salamander (Cuvier, 1828). In 1863, 34 axolotls were 
shipped to the Natural History Museum in Paris by General Forey of the French 
Expeditionary Forces in Mexico (Dumeril, 1870). Only 7 (6 black and 1 white axolotl) 
individuals were donated to Auguste Dumeril for scientific study, from which thousands 
of axolotls were bred and sent all over Europe (Dumeril, 1872). All the captive axolotls 
in the world were derived from those very animals imported to Paris (Smith, Armstrong, 
and Malacinski, 1989). 
 
Axolotls are excellent experimental animals as they are easy to breed in captivity, 
inexpensive to feed, very hardy and moderately large. The animals are easily induced to 
reproduce compared to other salamanders in their family, which are almost never 
captive bred axolotls reach lengths up to 30 cm (12 inches), on average of 20 cm (9 
inches) in length. The average mass of an adult animal is 85g (Brunst, 1955a). Axolotls 
play an important role in developmental studies (Bordzilovskaya, 1975) due to their 
amazing regenerative capabilities and large embryos, and because their large cells, are 
often used in histological studies (Brunst, 1955a; Smith, Armstrong, and Malacinski, 
1989). The axolotl limb is used as a model of tissue and organ regeneration. Amputation 
anywhere between the shoulder and the hand induces the formation of a mass of 
dedifferentiated proliferating cells called the blastema that regenerates the missing limb, 
which becomes fully functional (Brockes, 1997).  
 
 Axolotls are also used in heart defect studies due to the presence of a mutant gene that 
causes heart failure in embryos. Since the embryos survive almost to hatching with no 
heart function, the defect is very observable (Trottier and Armstrong, 1977; Kulikowski 
and Manasek, 1977). Another attractive feature for research is the presence of several 
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colour morphs. Axolotls have four different colours, two naturally occurring colours 
(dark brownish-green - wildtype and black - melanoid) and two mutants (pale pink with 
black eyes - leucistic and golden, tan or pale pink with pink eyes - albino) (Dunson, 
1974, Frost et al., 1984 and 1986) (Figure 14).  
 
 
Figure 14 Axolotl colour morphs (www.caudata.org) 
 
The axolotl is a neotonic amphibian, which means that it never undergoes 
metamorphosis, so the adult remains aquatic and gilled. The animal retains larval 
characteristics in the reproductive mature adult form. Neoteny appears to be maintained 
by a lack of thyroid stimulating hormone (TSH), which induces the thyroid to produce 
thyroxine (Prahlad and Delanney, 1965). In the axolotl, metamorphosis can be triggered 
under laboratory conditions via thyroid hormone injections like T3 (3, 3’, 5’-
triiodothyronine) (Swanberg and Norris, 1972, Norris and Platt, 1974), T4 (thyroxine) 
(Norris and Platt 1974), or TSH Norris et al., 1973, Taurog, 1974). The levels of those 
hormones are low in neotonic animals and drastically increase during metamorphosis 
(Platt, 1976). Tiger salamanders are able to undergo metamorphosis only in warm lakes, 
which suggests that some species can metamorphose naturally, depending on 
environmental and endocrinological conditions (Jenkin, 1970). 
 
 More recently, axolotls have been used in a variety of biological studies including 
cardiogenesis (Zhang et al., 2004, Denz et al., 2004, Cano-Martinez et al., 2010), 
embryogenesis (Bachvarova et al., 2004, Pelczar et al., 2010), genomics (Smith et al., 
2009), thyroid hormone (TH) distribution (Page et al., 2007), TH induced 
metamorphosis (Page et al., 2008; Page et al., 2009), sex determination (Park et al., 
2004; Smith and Voss, 2009) and organ and tissue regeneration (Schnapp and Tanaka, 
2005, Monaghan et al., 2007, Menger et al., 2010, Satoh et al., 2010). In terms of 
47 
 
genomics resources, an integrated web portal ‘Sal-Site’ is available 
(http://www.ambystoma.org) to provide new tools for studying axolotls and tiger 
salamanders. It hosts the salamander genome project, the Ambystoma EST database and 




Research arising from the discovery of leptin (Zhang et al., 1994) and experiments on 
leptin administration performed soon after that (Campfield et al., 1995; Pelleymounter 
et al., 1995; Halaas et al., 1995; Stephens et al., 1995) emphasised the role of leptin in 
mammals as an adiposity signal that circulates in the blood in proportion to energy 
stored as fat and acts in the brain to regulate energy balance. It had a major impact on 
obesity research as the neural circuits in the hypothalamus through which leptin acts to 
influence energy balance were identified (Sawchenko 1998). In particular, leptin's 
effects on body weight are mediated through effects on two separate populations of 
arcuate nucleus neurones that express the LEPR. One group expresses NPY and agouti 
related protein AgRP to increase food intake, and the other group expresses CART and 
POMC (from which alpha-MSH is derived), to reduce food intake (Lin et al., 2000). It 
became clear that the main role of these pathways is to coordinate responses to energy 
deprivation or restriction signalled by falling concentrations of plasma leptin (Baskin et 
al., 1999). Falling leptin concentrations therefore appear to be more important as a 
physiological signal than rising concentrations associated with obesity because they are 
linked to threats to survival such as starvation. In contrast, it became clear that high 
leptin concentrations in obese patients are linked to leptin resistance, reducing the 
possible effectiveness of leptin as an obesity treatment (Thorburn et al., 2000; Sinha and 
Caro 1998; Lee et al., 2002). Similarly, research on seasonal fattening cycles in 
mammals indicated that although leptin seems to coordinate short-term regulation of 
energy balance, seasonal obesity and leanness are not driven by changes in leptin 
production, and that seasonal fattening is associated with high leptin concentrations as a 
result of leptin resistance (Rousseau et al., 2003). 
 
The discovery of leptin in mammals also stimulated research into its physiological 
functions other than the regulation of energy balance. It has been demonstrated that 
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leptin regulates other physiological systems like reproduction (Karlsson et al., 1997; 
Caprio et al., 1999; Kitawaki et al., 2000; Hoggard et al., 1997; Ludwig et al., 2000; 
Mounzih et al., 1998), immune system (Grunfeld et al., 1996; Sarraf et al., 1997; Bennet 
et al., 1996; Faggioni et al., 1998; Otero et al., 2006; Lord et al., 1998), cardiovascular 
system (Rahmouni et al., 2003; Bouloumié et al., 1998, Fukuda et al., 2003) or 
development (Schubring et al., 1996; Steppan et al., 2000; Felson et al., 1993) and that 
the effects on these systems that leptin exerts are largely consistent with an overall 
action of leptin as a signal of nutritional state. Examples of positive selection on the 
leptin gene in mammals associated with the development of novel functions are rare.  
Changes in normally conserved regions of leptin have been linked in seals to a role for 
leptin in the stretch-induced surfactant production pathway, and leptin production in the 
lungs (Hammond et al., 2005). Molecular cloning and expression of leptin in gray and 
harbor seal blubber, bone marrow, and lung and its potential role in marine mammal 
respiratory physiology (Hammond et al., 2005). However, leptin was also expressed in 
seal blubber, suggesting that its role as an adipose tissue signal has been retained.  
 
For the decade following leptin’s discovery, leptin genes had only been unequivocally 
identified in mammals, raising the possibility that the hormone was specific to this 
vertebrate group. The fact that leptin has an ancient evolutionary history was only 
revealed with the discovery of leptin-like genes in fish and amphibian genome databases 
(Kurokawa et al., 2005). Although cytokine signalling is present in invertebrates, leptin 
signalling appears to have arisen only after the divergence of urochordates and 
vertebrates (Liongue and Ward, 2007). While structural motifs have been conserved 
between fish, amphibian and mammalian leptins, the overall sequence similarity 
between fish and mammalian leptins can be less than 20%, raising the possibility that 
the functions of the hormone have changed during evolution. 
 
To assess the idea that the role of leptin on food intake regulation has been conserved in 
different vertebrate groups, leptin administration experiments (often using mammalian 
leptin, but in some cases non-mammalian leptin) have been performed (Ashima et al., 
2000; Murashita et al., 2008; Aguilar et al., 2010; Niewiarowski et al., 2000; Li et al., 
2010). In most of the cases, treatment with recombinant leptin increases energy 
expenditure and decreases food intake, body weight and body fat stores (Ashima et al., 
2000; Murashita et al., 2008; Aguilar et al., 2010), implying conserved function during 
evolutionary history. However in some studies, the effect of leptin administration was 
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only temporary (Li et al., 2010; Niewiarowski et al., 2000) suggesting that although a 
general regulatory effect on energy balance has been conserved, the specific effects of 
leptin may differ between vertebrate groups. It is possible that leptin has been deleted 
from the avian genome, perhaps related to alterations in metabolism linked to the 
extreme aerobic requirements of flight. In ectotherms such as fish, the regulation of 
leptin expression by long term food restriction or deprivation appears different from 
mammals, and may be related to metabolic regulation being more flexible because they 
do not have to thermoregulate (Huising et al., 2006).  
 
Most of the research on leptin in non-mammalian vertebrates is being performed in fish. 
Research on amphibians is very limited by comparison (Boswell et al., 2006; Crespi and 
Denver, 2006). The studies have been performed on two species (Ambystoma tigrinum; 
Xenopus tropicalis) and the cDNAs identified share only 67% identity at the amino acid 
level (Crespi and Denver, 2006). This suggests that even within the same vertebrate 
group, leptin may have different functions due to genetic drift. More information is 
currently available for Xenopus than for the axolotl and it is the aim of this thesis to 
address this by extending investigation into the functions of leptin in salamanders. It is 
also the case that the effects of nutritional manipulation on leptin gene expression have 
not yet been investigated in any amphibian. This thesis will provide a new opportunity 
to investigate the functions of the leptin signalling system in these early tetrapod 
vertebrates, providing insight into the functional development of the system during 
vertebrate evolution. 
 
1.9.1 Aims and Objectives 
 
 
The aim of this thesis was to assess the structure and functions of leptin and LEPR in the 
axolotl. The project involved cloning the axolotl leptin and leptin receptor using 
information based on the sequence of the Ambystoma mexicanum leptin and the LEPR 
sequences from different species. The next step was to establish the pattern of tissue 
expression of leptin and its receptor in the adult and during development to extend 




In order to understand the possible role(s) of leptin in the regulation of food intake and 
energy metabolism in amphibians, leptin and LEPR gene expression was studied in 
response to short-term restriced feeding and feeding to satiation. 
 
Identification of amphibian leptin provides a scientific basis to clarify leptin’s molecular 






Chapter 2. Materials and Generic Methods 
 
2.1 Animals and tissues 
 
All animals were obtained from a captive breeding colony at the University of 
Birmingham, United Kingdom. They were maintained in shallow dechlorinated tap 
water in plastic boxes and were fed daily with chopped liver. The animals were 
humanely killed before dissection by immersion in 0.1% tricaine methane-sulfonate 
(ethyl 3-aminobenzoate methane-sulfonate) anaesthetic (Sigma, Poole, Dorset, UK), in 
accordance with the United Kingdom Home Office Code of Practice. The three groups 
of animals used for tissue distribution studies were males and females of 6 months, 10 
months and 3 years old. Body mass and length (snout to vent) was routinely recorded at 
the time of dissection (Table 2). Food was present in the gastrointestinal tract of all 
individuals at the time of dissection indicating that the animals were in a fed state. 
Following dissection, tissues were immediately incubated in RNAlater (Ambion, 
Applied Biosystems, Warrington, Cheshire, UK) at 4˚C overnight and were then frozen 
and stored at -80˚C. 
 
Several axolotl embryonic  and post-embryonic (hatched larvae, 44) stages were 
collected and stored in 1ml RNAlater (Ambion) at -80ºC until further processing. 
Axolotl embryonic development is divided into 44 stages based on external morphology 































92.6 113.3 101 116 108.2 103 93 
Length (cm) 13 14 14 15 13.5 14 13 
 
B 
6-month old 1 2 3 4 5 6 
Body mass (g) 13.2 15.5 16 16 24.9 9.5 

















27.4 27.8 21.5 28 15.5 
Length (cm) 9 9 7.5 8 8 
 
Table 2 Animals used for tissue distribution studies including three age groups (6 
months, 10 months and 3 years old). Body mass and length (snout to vent) was recorded 
at the time of dissection. (According to the guidelines for the format of theses, numbers 
and captions should appear at the bottom of the table/figure). 
 
2.2 Nucleic acid extraction 
 
Dissected tissues were stored in 1ml RNAlater (Ambion) at -80ºC until further 
processing. Total RNA was isolated from dissected tissues using TRI reagent according 
to the manufacturer’s instruction (Helena, Gateshead, UK). Individual tissues were 
homogenised in TRI reagent in Lysing Matrix D using a FastPrep Instrument 




Isolated total RNA was treated with DNase I (1U) (Amplification Grade 
Deoxyribonuclease I; Invitrogen, Paisley, UK or Promega, Southampton, UK) for 30 
min at 37ºC and inactivated by incubation at 75ºC for 10 min for digestion of the DNA. 
Visualization on a formaldehyde gel (2.9.1) showed that the RNA was not degraded.  
 
Poly (A+) RNA was isolated using an Oligotex mRNA Mini Kit (Qiagen, Crawley, UK) 
according to the manufacturer’s instructions. 
 
Genomic DNA for PCR was isolated from dissected ovaries using TRI reagent 
according to the manufacturer’s instructions (Helena, Gateshead, UK). The tissue was 
homogenised using a Fastprep Instument for 1x 40 sec at high intensity (4.5 m/s).  
 
DNA and RNA concentration was determined using a NanoDrop® ND-1000 UV-Vis 
spectrophotometer (Thermo Scientific, Loughborough, UK). 
 
2.3 cDNA synthesis 
 
First-strand cDNA was synthesized in 20 µl reactions with 2 µg of total RNA as 
template, using a SuperScript II synthesis kit (Invitrogen) and Oligo d(T)18 primer 
(Invitrogen). Reverse transcription was performed in 20 μl of solution containing 2 μg 
of total RNA, 1 μl of the oligo dT primer (500 μg/ml), 1 μl of dNTP mix (10 μM final 
concentration), 4 μl of 5x First-Strand Buffer, 2 μl of DTT (0.1 M) and 1 μl (50 U/μl) of 
SuperScript II Reverse Transcriptase and the mixture was incubated at 42 °C for 50 
min. The reaction was stopped by raising the temperature to 70 °C for 15 min. First-
strand cDNAs were diluted 5-fold with water and stored at -80ºC until further analysis 




PCR was performed using FastStart Taq polymerase (Roche Diagnostics, Lewes, East 
Sussex, UK) on a Gene Amp PCR system 9700 thermocycler block (Applied 
Biosystems). The reactions were carried out in 25 µl of solution containing 2.5 µl of 
10x PCR reaction buffer, 1.5 µl of MgCl2 (25 mM), 0.5 µl of dNTP (10 mM), 0.5 µl of 
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each primer (100 µM) and 0.2 µl of FastStart Taq polymerase (5 U/ µl).Primers and 
specific reaction conditions used for leptin, leptin receptor and cyclophilin are described 
below. Primers were designed using the Primer3 program 
(http://frodo.wi.mit.edu/primer3/) and were purchased from Sigma-Aldrich 
(Gillingham, Dorset, UK).  
 
2.5 Agarose gel electrophoresis 
 
To prepare 100 ml of a 2% agarose gel, 2 g of agarose was added to 100 ml of 1xTAE 
buffer (50x TAE buffer: 242 g Tris base, 57.1 ml glacial acetic acid, 100 ml of 0.5 M 
EDTA pH 8.0). The agarose was dissolved by boiling in a microwave oven. The 
solution was cooled to 60°C and 5 µl of ethidium bromide (10 mg/ml) was added. The 
gel was poured into the gel tray and left for 1h at room temperature to set. The samples, 
containing 6x loading buffer (Fermentas, York, UK), were then loaded, and the gel was 
run in 1xTAE buffer at 80 mV for 50 min. The DNA samples were visualized on a UV 
transiluminator and an image captured using Gel Doc Software Image Analysis (Bio-
Rad, Hemel Hempstead, Hertfordshire, UK). 
 




To clone axolotl leptin, two sets of PCR primers were designed based on a Tiger 
salamander (Ambystoma tigrinum) leptin-like EST deposited in GenBank (Accession 
No. CN054256). The primers used were:  forward primers 
5’ATCCCAACCTTCCACTGTC, SalLep1 (positions 90–108 of Accession 
No.CN054256), 5’TCTTCTCCCGATGAACCTGAA, AxLep1 (positions 184-203 of 
Accession No. CO792338); and reverse primers 5’ACCTATCCAACGCAACTTTC, 
SalLep2 (positions 479–498 of Accession No.CN054256), 
5’TTTGTGGGAGTTGGACACAA, AxLep2 (positions 594-613 of Accession No. 




PCR for leptin cDNA was performed (as described above), with an annealing 
temperature of 60°C and denaturing and extension steps of 94°C and 72°C, respectively. 
Times used were 15 sec denaturation, 30 sec annealing, and 30 sec extension, with an 
extension time for the final cycle of 7 min. PCR was carried out for 30 cycles. PCR 
amplification products were separated by electrophoresis on a 2% agarose gel, 
whereupon specific bands were excised and purified by the QIAquick gel extraction kit 
(QIAgen GmbH, Germany). Purified PCR products were cloned into pSC-A-amp/kan 
with subsequent transformation in StrataClone SoloPack competent cells according to 
the manufacturer’s instructions (StrataClone PCR cloning kit, Stratagene, Agilent 
Technologies, Stockport, Cheshire, UK). Positive white colonies were cultured and 
plasmid DNA was extracted using a PureLink Quick Plasmid Miniprep kit (Invitrogen). 
The insert was sequenced from 6 clones in both directions using M13F and M13R, 
respectively.  
 
Genomic DNA (300 ng) was also used as a template to amplify the axolotl leptin gene 
using FastStart Taq polymerase. The primers used were the same as for leptin cDNA 
amplification. The denaturation, annealing, and extension temperatures and times were 
94°C, 15 sec; 60°C, 30 sec; and 72°C, 3:30 min; with the final extension step of 7min. 
PCR was carried out for 30 cycles.  Visualization of PCR amplification product was 
shown on 1% agarose gel. 
 
2.6.2 Leptin receptor 
 
For analysis of tissue distribution of gene expression, PCR primers were designed from 
the cloned cDNA fragment of the axolotl leptin receptor (Accession No. GU562414). 
The primers used were: forward primer 5’-TCTCTTGTGAAACCGATGGA, AxLEPR1 
(positions 6-25 of  Accession No.GU562414); and reverse primer 5’-
GCAACGAGCAGTCTTTTGATT, AxLEPR2 (positions 156-176) yielding a reaction 
product of 171bp. PCR was carried out as described above with an annealing 
temperature of 56°C and denaturing and extension steps of 94°C and 72°C, respectively. 
Times used were 15 sec denaturation, 30 sec annealing, and 30 sec extension, with an 
extension time for the final cycle of 7 min. PCR was carried out for 30 cycles. 
Amplification products were separated on a 2% agarose gel and visualized using 




PCR was also used to amplify a fragment of axolotl leptin receptor gene using FastStart 
Taq polymerase and 300 ng genomic DNA as template. The primers used were the same 
as for LEPR cDNA amplification. The denaturation, annealing, and extension 
temperatures and times were 94°C, 15 sec, 54°C, 30 sec; and 72°C, 1:30 min; with the 
final extension step of 7 min. PCR was carried out for 30 cycles.  Visualization of PCR 




To confirm the effectiveness of reverse transcription, PCR was also carried out to 
amplify a cDNA fragment of cyclophilin A. Primers were designed from an axolotl 
(Ambystoma mexicanum) EST (Accession No. BI818006). The forward primer was 5’-
CTTCACAAACCACAATGGAAC, AxCycF1 (positions 212–232 of BI818006) and 
the reverse primer was 5’-ACAGATGAAAAACTGGGAGC, AxCycR1 (positions 
340–359), yielding a reaction product of 148 bp.  
 
PCR for cyclophilin A cDNAs was performed as described above with an annealing 
temperature of 60°C and denaturing and extension steps of 94°C and 72°C, respectively. 
Times used were 15 sec denaturation, 30 sec annealing, and 30 sec extension, with an 
extension time for the final cycle of 7 min. PCR was carried out for 30 cycles.  
 
2.7 RTqPCR analysis 
 
Quantitative real-time PCR assay was established for relative quantification of axolotl 
leptin and its receptor. Melting curve analysis, gel electrophoresis and sequencing 
assessed the identity of the products. RNA isolation using the Tri reagent resulted in 
high quality total RNA with A260/A280 ratios between 1.80 and 2.10. Total RNA 
isolated from 12 different tissues and was reverse-transcribed into cDNA for PCR 




The assays for leptin, leptin receptor and cyclophilin were set up using the primers 
described above. All primers had Tms between 58ºC and 63.2ºC, and a GC content 
between 43 and 53% (Table 3). 






Leptin F  5’ATCCCAACCTTCCACTGTC 58 53 409 
Leptin R 5’ACCTATCCAACGCAACTTTC 58 45  
LEPR F 5’TCTCTTGTGAAACCGATGGA 63.2 45 171 
LEPR R 5’GCAACGAGCAGTCTTTTGATT 63.2 43  
Cyclophilin F 5’CTTCACAAACCACAATGGAAC 49 43 148 
Cyclophilin R 5’ACAGATGAAAAACTGGGAGC 58 45  
 
Table 3 Primers used for RTqPCR analysis 
 
RTqPCR reactions were performed in a total volume of 25 μl, containing  2 μl of diluted 
cDNA template (1:5), 12.5 μl of SYBR greenER qPCR SuperMix universal (including 
Taq polymerase, reaction buffer, MgCl2, SYBR Green I dye, and dNTP mix (with 
dUTP instead of dTTP); Invitrogen), 0.5 μl of forward and 0.5 μl of reverse primers (10 
μM each). The PCR reaction was carried out on a PTC-200 Peltier Thermal Cycler 
Chromo 4 (MJ Research/Bio-Rad Laboratories, Hemel Hempstead, Herts, UK) with the 
following parameters: 1 cycle of 50°C for 2 min; 95°C for 10 min; 40 cycles of 95°C 
for 15 sec, 60°C for leptin and cyclophilin or 56°C for leptin receptor for 30 sec. 
 
Specificity of RT-PCR products was confirmed with gel electrophoresis and resulted in 
a single product with the predicted length (leptin - 409 bp; LEPR - 171 bp; cyclophilin - 
148 bp). 
 
Fluorescent reading at high temperature at the end of the fourth PCR segment (just 
below the melting temperatures of our amplicons) melts unspecific PCR products (e.g., 
primer dimers) and assures quantification of specific product only (Pfaffl, 2001). 
Directly after the PCR, the machine performed a melting curve analysis by slowly (0.2 
_C/s) increasing the temperature from 60 to 95ºC, with a continuous registration of 
changes in fluorescent emission intensity. The software plots the rate of change of the 
relative fluorescence units (RFU) with time (T) (-d(RFU)/dT) on the Y-axis versus the 
temperature on the X-axis, and this will peak at the melting temperature (Tm). The 
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melting curve was read every 0.2 seconds and was held every 0.01 second. The absence 
of nonspecific products was indicated by observation of a single melting peak in 
melting curve (leptin 83°C; LEPR 78°C; cyclophilin 79°C) analysis by measuring the 





Figure 15 Melting curve analysis of the qrtRT-PCR amplification products using 
primers for leptin, leptin receptor and cyclophilin (Opticon Monitor software, Promega). 
 
For  each  gene,  a minimum  of  5  independent  replicates were  carried out for 






The samples were analysed and compared to axolotl cyclophilin as a reference gene, 
which gave similar results on the relative expression of leptin receptor, indicating that 
cyclophilin can be reliably used as a reference gene in the studies. A graph was plotted 
using the ratio values obtained and standard deviation of these values were calculated 
and shown as error bars in the graph. 
 
Serial dilutions of plasmid DNA containing leptin and leptin receptor and cyclophilin 
inserts (target and reference genes), respectively, were made to assess PCR efficiency 
and which dilutions to use for the unknown samples. Calculation of PCR efficiency (E) 
was based on the slope of the relationship between log input cDNA vs the threshold 
cycle (Ct is defined as the point where the fluorescence increases above a background 
threshold level, which was determined as the second derivative maximum): E= .  
 
The Ct for leptin usually lay between 22 and 40, for LEPR 24 and 40, while those of 
cyclophilin were between 11 and 22. Using equal amounts of cDNA for the qRT-PCR, 
neither cyclophilin nor leptin and LEPR varied between samples taken from different 
animals. 
 
To calculate PCR efficiency log [cDNA] serial dilutions vs Ct were plotted and gave 
R
2
> 0.97 (Figure 16). Investigated transcripts showed high real-time PCR efficiency 












Figure 16 QrtRT-PCR dilution curves. Standard curve based on dilutions of leptin (A), 
LEPR (B) and cyclophilin (C) gene inserted into the pSC-A-amp/kan vector. 
 
To quantify relative expression levels an efficiency-corrected relative expression 
method (Pfaffl, 2001; Roche Applied Science, 2001) was used: 
 
Relative expression =  
 
Each assay included no-template-controls (substituting cDNA with water or RNA) for 
each primer pair to confirm that reagents were not contaminated. 
Data are expressed as means ± standard error of mean (SEM). The significance level 





The results obtained from real-time PCR for tissue expression were analysed by one-
way and two-way Analysis of Variance (ANOVA) using SPSS software. Data were 
tested for normality and were log-transformed before analysis. Post hoc analysis was 
performed using Fisher’s Least Protected Difference test. The level of statistical 
significance was set at p<0.05. 
 
2.9 Northern blot 
 
2.9.1 Agarose gel containing 2.2 M formaldehyde 
 
To prepare 100 ml of a 1% agarose gel containing 2.2 M formaldehyde, 1 g of agarose 
was added to 72 ml of sterile water. The agarose was dissolved by boiling in a 
microwave oven. Subsequently, 10 ml of 10xMOPS electrophoresis buffer (10x MOPS: 
0.4 M MOPS (pH 7.0) (3-[N-morpholino]propanesulfonic acid, 0.1 M sodium acetate, 
0.01 M EDTA (pH 8.0) ), 18 ml of formaldehyde (12.3 M) and 3 μl of ethidium 
bromide (10 mg/ml) were added to the agarose. 
 
2.9.2 RNA sample 
 
To each sample amount of poly(A
+
) RNA, 2x RNA loading dye (Fermantas, R0641) 
was added and incubated for 10 min at 65
0
C to denature RNA. The RNA samples and 
ready-to-use high range RNA ladder (Fermantas, SM0423) were loaded into the wells 
of the submerged gel, which was run in 1xMOPS electrophoresis buffer at 70 mV until 
the bromophenol blue had migrated ~5cm. 
 
2.9.3 Transfer to positive charged nylon membrane at alkaline pH  
 
The RNA was then transferred to a hybridisation membrane cut to the size of the gel. At 
this stage a corner of the membrane was cut to assist later in orientation. Transfer was 
carried out by vacuum blotting. The vacuum blotting apparatus was assembled during 
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the gel electrophoresis step as follows. A sheet of Whatman 3MM filter paper 5cm 
larger than the gel was cut and pre-wet in distilled water and placed on to the screen. 
The positively charged nylon membrane was cut to a slightly larger size than the gel, 
pre-wet in distilled water and positioned on the filter paper. RNA was transferred from 
the gel in 5x SSC with 10 mM NaOH (20x SSC: 175 g sodium chloride, 88 g trisodium 
citrate, pH 7.0 (HCl), H2O to 1 litre). The pre-wet rubber mask was placed over the 
membrane. The rubber mask had a template cut such that the window is 5mm smaller 
than the gel. The gel was transferred in a position such that the opening in the rubber 
mask was in contact with the membrane. A suitable vacuum was applied. The 
transferred buffer (5x SSC with 10 mM NaOH.) was poured on to the surface of the gel. 
The transfer was carried out for 4 h after which fixing of the RNA was carried out by 
UV crosslinking (GS Gene Linker UV chamber,Bio-Rad, 150 mJ/cm2). Membranes not 







Up to 9 µg of extracted poly(A
+
) RNA from axolotl testis was denatured at 65°C for 10 
min and was then separated on a 1% agarose gel containing: 1x MOPS (10x MOPS = 
0.4 M 3-(N-morpholino) propanesulfonic acid, 0.1 M sodium acetate, 0.01 M disodium 
EDTA, pH 7.0) and 2.2 M formaldehyde). Ethidium bromide (0.01 mg) was added to 
the gel and 1xMOPS running buffer. RNA transcript size was determined using a RNA 
size marker (Fermentas, York, UK) After electrophoresis, the RNA was transferred onto 
a positively charged nylon membrane (Roche, Burgess Hill, West Sussex, UK) by 
vacuum blotting with 5x SSC, 10 mM NaOH transfer buffer for 6 h and crosslinked 
(150 mJ/cm
2
, GS Gene Linker UV chamber, Bio-Rad, Hemel Hempstead, 
Hertfordshire, UK). Prehybridization was carried out by incubating the membrane in 10 
ml of Ultrahyb-Oligo hybridization solution (Ambion) for 30 min at 42°C in a 
hybridization oven. For radioactive detection of the blotted RNA, three oligonucleotides 
designed from the cloned leptin and LEPR sequences (Sigma-Genosys, Haverhill, 
Suffolk, UK) were labelled with 
32
P-ATP (6000 Ci/mmol, PerkinElmer, Beaconsfield, 
UK) using a Kinase Max kit (Ambion). The oligonucleotide probes used for the 











Table 4 Primers used for Northern Blot 
 
All three probes for LEPR and two probes for leptin were added to the hybridization 
solution. Hybridization with agitation was performed overnight in a hybridization oven 
at 42°C. After hybridization, the membrane was washed twice for 30 min in 2x SSC, 
0.5% SDS; once for 30 min in 1x SSC, 0.5% SDS; once for 30 min in 0.5x SSC, 0.5% 
SDS; and once in 0.1x SSC, 0.5% SDS, all at 42°C. The membrane was wrapped in 
clingfilm and exposed for 2 weeks to Kodak BioMax MS autoradiographic film. The 
film was processed by hand as follows: 30 sec in X-ray developer (Ilford Phenisol 
Developer, Herman technology Ltd., Town Lane, Cheshire, UK), 1 min in water bath, 
1min in fixer (Polymax RT fixer, Kodak Professional, Hemel Hempstead, 
Hertfordshire, UK) and 5 min in water bath. 
 
2.10 Molecular phylogeny 
 
Phylogenetic trees were constructed by using the Maximum Likelihood method based 
on the Equal Input model (Tajima and Nei, 1984). The trees with the highest log 
likelihood were shown. The percentage of trees in which the associated taxa clustered 
together was shown next to the branches. Initial trees for the heuristic search were 
obtained automatically as follows. When the number of common sites was <100 or less 
than one fourth of the total numbers of sites, the maximum parsimony method was 
obtained; otherwise BIONJ method with MCL distance matrix was used. Evolutionary 








To understand the physiological effects of leptin, it is necessary to study the structure 
and function of its receptor. Until recently, leptin receptor had only been identified in 
mammals, so information on the evolution of the leptin signalling pathway and its 
functions in vertebrates is very limited. Most of the research on leptin receptor in non-
mammalian vertebrates is being performed in fish. A full-length LEPR gene has been 
identified from marine medaka (Oryzias melastigma) (Wong et al., 2007), pufferfish 
(Takifugu rubripes) (Kurokawa et al., 2008), Japanese medaka (Oryzias latipes) 
(Kurokawa, Murashita, 2009) and Atlantic salmon (Salmo salar) (Ronnestad et al., 
2010). The fish LEPR genes share less than 25% identity to mammalian leptin 
receptors. Sequences among the fish LEPR genes show 82-32.5% similarity at amino 
acid level.  
 
Although the chicken leptin gene is missing, there is evidence that a leptin-like 
signaling system is present in birds because receptor sequences have been cloned in the 
chicken and turkey that share greater than 90% sequence identity at both the nucleotide 
and amino acid level (Horev et al., 2000; Ohkubo et al., 2000; Richards et al., 2003). 
The identity between chicken and mouse LEPRs is 60% at amino acid level, indicating 
a relatively low similarity (Horev et al., 2000). Evidence also exists at the protein level 
for the LEPR in reptiles. LEPR-like immunoreactivity was detected in the pancreas 
(Paolucci et al., 2006), thyroid gland (Sciarrillo et al., 2005) and testis (Putti et al., 2009) of 
the lizard, Podarcis sicula. 
 
Research on the amphibian LEPR is very limited. Only one LEPR gene has been reported in 
amphibians (Xenopus tropicalis) sharing 37% amino acid sequence identity with human 
(Crespi and Denver, 2006). Therefore, the aim of this chapter is to assess the structure and 
functions of leptin receptor in the axolotl via cloning the axolotl LEPR and establishing the 
pattern of its tissue expression in the adult and during development to extend investigation 






3.2.1 Cloning of axolotl leptin receptor 
 
Amino acid sequences of Xenopus tropicalis (ABD63000), human (NP_002294), mouse 
(NP_666258) and Zebrafish leptin receptor (NP_001106847) were aligned with 
ClustalW2 (http://www.ebi.ac.uk/Tools/clustalw2). Semi-degenerate primers were then 
designed using the CodeHop program (Rose et al., 1998). The primers used were: 
forward primer 5’ GCCGAGATCTACGTGATCGAYGTNAAYAT (CHOPF2) and 
reverse primer 5’ AGGAAGACGGGCTGGAAGRTRCAYTCRTA (CHOPR2), 
yielding a reaction product of 248bp. PCR was performed using cDNA from an axolotl 
hatched larva as template. A touchdown program was used with the annealing 
temperature decreasing from 63°C to 53°C, in increments of 0.5°C. Denaturing and 
extension steps were 94°C and 72°C, respectively. Times used were 15 sec 
denaturation, 30 sec annealing, and 30 sec extension, with an extension time for the 
final cycle of 10 min. PCR was carried out for 40 cycles. PCR products were visualised 
on a 2% agarose gel as described above. Amplification products were extracted from the 
agarose gel using a QIAquick gel extraction kit (Qiagen) ligated into pSC-A-amp/kan 
vector and transformed into Strataclone SoloPack competent cells using a StrataClone 
PCR cloning kit (Stratagene). Plasmid DNA was isolated using a PureLink Quick 
Plasmid Miniprep kit (Invitrogen) according to the manufacturer’s instructions, and was 
then sequenced. The sequence was obtained in forward direction from seven clones 
amplified from testis. The partial LEPR sequence was submitted to GenBank and given 
the accession number GU562414. 
 
Methods for PCR amplification of the LEPR fragment are described in Chapter 2 
(General Methods). 
 
3.2.2 3’ RACE 
 
To assess the 3’ region of the axolotl LEPR gene, the 3’ RACE System for Rapid 
Amplification of cDNA Ends (Invitrogen) was used. Total RNA was extracted from the 
axolotl brain using the the TRIzol reagent following the manufacturer's instructions. 
The 3′ rapid amplification of cDNA ends (RACE) was used to attempt to generate 
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axolotl LEPR cDNAs. The 3′ ends of the cDNAs were amplified with a specific forward 
primer (5’-TCTCTTGTGAAACCGATGGA) and reverse random primers from the 3’ 
RACE cDNA amplification kit following the manufacturer's instructions. The 
denaturation, annealing, and extension temperatures and times were 94°C, 15 sec; 54°C, 
30 sec; and 72°C, 3 min; with the final extension step of 7 min. PCR was carried out for 
30 cycles. One hundred ng of control RNA was used to amplify 3’ RACE product as a 
positive control according to the manufacturer's instructions. PCR amplification 
products were separated by electrophoresis on a 1% agarose gel, and putative specific 
bands were excised and purified by the QIAquick gel extraction kit (QIAgen GmbH, 
Germany), cloned using a StrataClone PCR cloning kit (Stratagene) and sequenced. 
 
3.2.3 3’ and 5’ RACE 
 
To assess the 3’ and 5’ region of the axolotl LEPR gene, RACE reactions were 
performed using a SMART RACE cDNA amplification kit (Clontech-Takara Bio 
Europe, Saint-Germain-en-Laye, France). First-strand cDNA was synthesized with 50 
ng of polyA
+
 RNA as template, isolated from the axolotl brain. The 5'-RACE and 3'-
RACE reactions were performed with gene-specific primer (GSP) based on the partial 
axolotl LEPR gene (Accession No. GU562414, the nucleotide sequences obtained from 
the previous degenerate-primer PCR) and Universal Primer A Mix (UPM) according to 
the manufacturer's instructions. For the GSPs, GSP1 used for 5'-RACE was 5'-
CGTCATCATCCCGCAACGAGCAGTCTTT; and GSP2 and GPS3 for 3'-RACE were 
5'-TGACATGCAGATGGCATCGGGGCAACA; 5’-
GTGGGGTGCGTGTGGACTGGTGCTTGC. Touchdown PCR was performed using 
the Advantage 2 PCR kit (Clontech). The reaction mix was prepared and the touchdown 
PCR was performed according to the manufacturer's instructions. The amplified 
products were purified from the gel, cloned and then sequenced. To ensure that the 
SMART RACE protocol was working efficiently, a positive control experiment was 
performed using the RACE- Ready cDNA generated from the Control Human Placenta 





3.2.4 DNA walking 
 
To obtain the 5′ region of the axolotl LEPR gene, cDNA and genomic walking were 
performed using the DNA Walking SpeedUp Premix Kit II (Biogene, Kimbolton, 
Cambs, UK). The 5’ region was amplified using 50 ng of cDNA and 100 ng of whole 
genomic DNA, respectively. Primary PCRs were performed using adaptor primers 
(DW2-ACP 1-4) from the kit and an outer gene-specific primer TSP1 (LEPRR2 - 5’-
GCAACGAGCAGTCTTTTGATT). PCR reactions were performed in 20 μl using 
Master Mix from the kit according to the to manufacturer's instructions. The cycling 
conditions were: 1x 94°C for 5 min, 42°C for 1 min, 72°C for 2 min; 30x 94°C for 30 
sec, 60°C for 30°C for 30 sec, 72°C for 1:40 min and  1x 72°C for 7 min. Secondary 
PCRs were performed using primers DW-ACPN  and TSP2 (LEPRR1 - 5’-
TTCCGAAGTGTTCTGAATGGT). Three μl of the purified PCR products from the 
first PCR reactions were used with cycling conditions: 1x 94°C for 3 min; 35x 94°C for 
30 sec, 60°C for 30 sec, 72°C for 1:20 min and 1x 72°C for 7 min.  
The third PCR reactions used primers UP and TSP3 (LEPRR3 - 5’-
GGTTGGTGGCAAAGAACAGT; LEPRR4 - 5’-ATGCCGCTGCTGTAGTACCT) 
containing 2μl of second PCR products as template. The cycling conditions were: 1x 
94°C for 3min; 30x 94°C for 30sec, 65°C for 30sec, 72°C for  1:20min and 1x 72°C for 
7min.  PCR products of the third reaction were purified, cloned and sequenced. 
 
3.2.5 Use of LEPROT to design primers for the LEPR 
 
To obtain the 5’ end of the axolotl LEPR gene, primers were designed to the 5’ exons of 
the axolotl LEPROT sequence (Accession number CO789347) on the basis that the 
axolotl LEPROT and LEPR share common exons as they do in other vertebrates (Huang 
et al., 2002). The primers were: LeprOTF1 - 5’- GCCATACGAATCAGTGACGA; 
LeprOT2 - 5’-TCAGTGACGATACCGATGCT. PCRs were performed using the 
LEPROT primers as forward primers and either oligo dT primers, or LEPR gene 
specific primers (LEPR1 - 5’ TTCCGAAGTGTTCTGAATGGT; LEPR2 - 5’- 
GCAACGAGCAGTCTTTTGATT; LEPRR3 - 5’-GGTTGGTGGCAAAGAACAGT; 
LEPRR4 - 5’-ATGCCGCTGCTGTAGTACCT) as reverse primers.  PCR amplification 
was performed using the Expand High Fidelity PCR System (Roche). The PCR 
reactions were prepared according to the manufacturer's instructions and performed in a 
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total volume of 50 µl containing 200 µM of each dNTP, 300 nM of each primer, 1x 
Expand High Fidelity Buffer with 15 mM MgCl2, 2.6 U of Expand High Fidelity 
enzyme mix and 50 ng of the axolotl brain cDNA as a template. The cycling conditions 
were: 1x 94°C for 2 min; 10x 94°C for 15 sec, 56°C for 30 sec, 72°C for  2 min; 20x 
94°C for 15 sec, 56°C for 30 sec, 72°C for 2 min + 5 sec (cycle elongation for each 
successive cycle)  and 1x 72°C for 7 min. The PCR products were cloned and 




3.3.1 Cloning of axolotl leptin receptor 
 
A partial cDNA sequence, corresponding to a leptin receptor gene was isolated and 
sequenced from the axolotl (Ambystoma mexicanum) hatched larvae. The primer set was 
designed within the extracellular domain containing the ligand binding region, expected 
to be present in all forms of leptin receptor (Richards et al., 2003). The cDNA fragment 
consisted of 248 bp including the semi-degenerate primers (Figure 17) and the 190 bp 
axolotl-specific LEPR fragment was deposited in GenBank (Accession number 
GU562414). The predicted amino acid sequence shares 54-61% similarity with 
mammalian LEPRs, including 57% similarity with the human. Among non-mammalian 
LEPRs, sequence identity was 49% and 48% in the turkey and chicken, respectively, 
46% in Xenopus tropicalis, and less than 30% with fish LEPRs (Figure 18). The cloned 
region is part of the extra-cellular domain and corresponds to the part of the C2 domain 









Figure 17 Nucleotide and amino acid sequence of LEPR from the axolotl. The positions 
of the semi-degenerate primers in the nucleotide sequence are in bold and underlined. 
The predicted amino acid sequence does not include the primers. 
 
 
Figure 18 Amino acid alignment of vertebrate LEPRs on the basis of amino acid 
sequences of LEPR in chimpanzee (Pan troglodytes; XP_001161897), human (Homo 
sapiens; AAB09673), little brown bat (Myotis lucifugus; AAU47264), pig (Sus scrofa; 
ACT52816), cow (Bos taurus; DAA31276), sheep (Ovis aries; AAP33683), mouse 
(Mus musculus; CAM20702), rat (Rattus norvegicus; BAA12698), rhesus macaque 
(Macaca mulatta; AAF35388), chicken (Gallus gallus; AAF31355), turkey (Meleagris 
gallopavo; AAG40323), duck (Anas platyrhynchos; ACF17729), Xenopus tropicalis 
(ABD63000), Indian medaka (Oryzias melastigma; ABC86922), axolotl (Ambystoma 
mexicanum; GU562414, excluding primer sequences) and zebrafish (Danio rerio; 
NP_001106847) sequences. 
 
In order to investigate the gene structure of LEPR, PCR amplification of axolotl 
genomic DNA was performed with the same primers used for cDNA amplification. This 
yielded a 171bp fragment, (Figure 19), the same product size as obtained using a cDNA 
template, indicating that the cloned LEPR fragment contained no introns. However, 
splice site prediction programs (www.fruitfly.org/seq_tools/splice.html; 
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http://www.cbs.dtu.dk/services/NetGene2/) predicted splice donor and acceptor sites 
with confidence scores of 0.90 and 0.37, respectively (at nucleotide positions 122-136; 
116-133).  
 
Figure 19 Amplification of axolotl genomic DNA using the cDNA primers. Lane 1 
represents generated amplification product (171 bp) from axolotl genomic DNA 
template. M designates size marker and lane 2 represents no template control. 
 
3.3.2 Molecular phylogeny  
 
Phylogenetic analysis of the axolotl LEPR fragment in relation to other vertebrate 
LEPRS was performed using the deduced amino acid sequences and comparing it to the 
equivalent region of leptin receptor sequences available in GenBank (Figure 20). The 
phylogenetic tree shows that the evolutionary relationships between the axolotl LEPR 







Figure 20 A phylogenetic tree (phylogram) constructed on the basis of amino acid 
sequences of LEPR in chimpanzee (Pan troglodytes; XP_001161897), human (Homo 
sapiens; AAB09673), pig (Sus scrofa; ACT52816), cow (Bos taurus; DAA31276), 
mouse (Mus musculus; CAM20702), rat (Rattus norvegicus; BAA12698), chicken 
(Gallus gallus; AAF31355), turkey (Meleagris gallopavo; AAG40323), Xenopus 
tropicalis (ABD63000), Indian medaka (Oryzias melastigma; ABC86922), axolotl 
(Ambystoma mexicanum; GU562414), Takifugu rubripes (BAG67079), Atlantic salmon 
(Salmon salar; BAI23197), human OSMR (AAI25210) and human LIFR (P42702). The 
tree was calculated using the Maximum Likelihood method based on the Equal Input 
model (Tajima and Nei, 1984) and drawn using the MEGA5 program (Tamura). The 
tree with the highest log likelihood (-1505.9443) is shown. The analysis involved 12 
amino acid sequences. There were a total of 136 positions in the final dataset.  Numbers 
at branch points represent the bootstrap value for 1000 replicates as percentages and 
indicate the statistical reliability of a node in the tree.  Human oncostatin M receptor 






3.3.3 Attempts to access the full length of the axolotl LEPR cDNA 
 
In order to obtain the full length sequence of the LEPR cDNA, several techniques were 
performed including:  PCR with oligo dA; 3’ RACE; 5’ RACE and DNA walking. 
However, none of the above methods succeeded in allowing the sequence beyond the 
cloned fragment to be identified. 
 
To obtain the 3’ region of the axolotl LEPR cDNA, PCR was performed using a gene-
specific primer and oligo dA as a reverse primer. The experiment produced numerous 
products; however, following sequencing, none of them shared any similarities with the 
LEPR.  
 
The 3′ end of the cDNAs were amplified with a specific forward primer and reverse 
random primer from the 3’ RACE System for Rapid Amplification of cDNA Ends. The 
primers generated a 1.2 kb fragment from PCR of cDNA template extracted from 
axolotl brain (Figure 21). The sequence of this product did not show any similarities to 
LEPR. The positive control yielded an expected 720 bp fragment (Figure 22) indicating 
that the method was performed correctly. 
 
 
Figure 21 3’ RACE product using control RNA. Lane 1 represents generated 






Figure 22 3’ RACE amplification of the axolotl LEPR gene. A 200-ng sample of RNA 
extracted from the axolotl brain was used for first strand cDNA synthesis. M represents 
size marker; lane 1 –yielded amplification product (1.2 kb) and lane 2 - no template 
control. 
  
To assess the 3’ and 5’ region of the axolotl LEPR gene, RACE reactions were 
performed using a SMART RACE cDNA amplification kit. Axolotl LEPR specific 
primers were used in combination with a universal primer mix (UPM).  The touchdown 
PCR was performed followed by nested PCR using LEPR-specific nested primer in 
combination with the nested universal primer (NUP). The PCR products were 
sequenced and analysed, however the sequences were not similar to LEPR.  To ensure 
that the SMART RACE protocol works, a positive control experiment was performed 
using the RACE- Ready cDNA generated from the Control Human Placenta Total 
RNA. The reactions yielded the expected fragment sizes of 2.6 kb (3’ RACE) and 2.9 





Figure 23 Positive control SMART RACE experiment. Lane 1 represents amplified 5’ 
RACE fragment (2.9 kb); lane 2 – 3’ RACE fragment (2.6 kb); M designates size 
marker. 
 
To obtain the 5′ region of the axolotl LEPR gene, cDNA and genomic walking were 
performed using DNA walking SpeedUp Premix Kit II. The DNA walking experiment 
included three reactions: the first PCR reaction used the outer adaptor primers DW-ACP 
(1-4) from the kit and an outer gene-specific primer TSP1 (LEPRR2); the second 
reaction used primers DW-ACPN and TSP2 (LEPRR1); the third reaction used primers 
UP and TSP3 (LEPRR3; LEPRR4). PCR products of the third reaction were purified, 











Figure 24 DNA walking; 50 ng of cDNA and 100 ng of whole genomic DNA were 
used for cDNA (A) and genomic walking (B) PCRs, respectively. DW-ACP1 (lane 1 
and 5); DW-ACP2 (lane 2and 6); DW-ACP3 (lane 3 and 7) and DW-ACP4 (lane 4 and 
8) were used for amplification of 5’ region of the axolotl LEPR gene. As TSP3 primer 
LEPRR3 (lane1-4) and LEPRR4 (lane 5-8) were used. M represents size marker. 
 
To obtain the 5’ region of the axolotl LEPR gene, PCRs were performed using forward 
primers based on the axolotl LEPROT sequence. Either a range of LEPR gene specific 
primers (LEPR 1-4) or oligo dA were used as reverse primers. The experiment produced 
numerous products; however, following sequencing, none of them shared any 
similarities with the LEPR.  
 
3.3.4 Northern analysis 
 
Northern hybridization was carried out using poly(A)+ RNA extracted from axolotl 
testis with oligonucleotide LEPR probes designed from the cloned axolotl LEPR cDNA. 
Radioactive detection indicated a single band of RNA with a molecular size of 





Figure 25 Northern hybridization of LEPR poly(A)+RNA isolated from axolotl testis. 
A 9 µg aliquot of poly(A)+ RNA was electrophoresed through a 1% agarose 
formaldehyde gel, transferred to a nylon membrane, and hybridized with 32P-labeled 
antisense axolotl leptin receptor oligonucleotides. The hybridization signal was captured 
digitally after overnight exposure to a film. The transcript detected is approximately 3 
kb in size. M indicates RNA size ladder. 
 
3.3.5 Developmental expression of LEPR gene during axolotl embryogenesis 
 
The developmental expression of LEPR mRNA was analyzed by RT-PCR derived from 
11 axolotl embryonic stages (9, 12, 15, 17, 20, 25, 29, 35, 37, 39, 42) and 1-post-
embryonic stage (44- hatched larvae). LEPR expression peaked in early development at 
the late gastrula stage and became progressively weaker during neurulation so that it 
was barely detectable during the tailbud stages (stages 29-32), but increased markedly 




Figure 26 RT-PCR analysis of LEPR during embryogenesis and early larval 
development. Expression of cyclophilin in the same samples is shown for comparison. 
 
3.3.6 Tissue expression of axolotl LEPR gene using RT-PCR 
 
The distribution of axolotl LEPR expression was studied by RT-PCR on mRNA 
isolated from a variety of tissues in 5 individual animals (10-month old). Amplification 
of cyclophilin confirmed the effectiveness of reverse transcription. LEPR expression 
differed between the individuals studied. However, the strongest intensity of the PCR 
product was consistently observed in the brain with moderate expression also being 






Figure 27 Tissue distribution of LEPR mRNA in the axolotl using RT-PCR. For each 
individual, the distribution for cyclophilin mRNA is shown in the upper panel, and for 
leptin mRNA in the lower panel. Identical lanes were used for leptin and cyclophilin in 
each individual. Tissue abbreviations: Sk Msc, skeletal muscle; Mid SI, mid small 
intestine; Stom, stomach; Fat, fat body; NC, negative control (no template); PC, positive 
control. 
 
3.3.7 Tissue expression of Tiger salamander LEPR gene using RT-PCR 
 
A partial cDNA sequence, corresponding to the cloned fragment of the axolotl LEPR 
cDNA was isolated and sequenced from Tiger salamander (Ambystoma tigrinium) 
skeletal muscle. The cDNA fragment consists of 171 bp and shares 100% similarity 
with the axolotl LEPR at the amino acid level. Tiger salamander LEPR tissue 
distribution was studied by RT-PCR on mRNA isolated from a variety of tissues in 
three different animals. To confirm the effectiveness of reverse transcription, PCR was 
also carried out to amplify a cDNA fragment of cyclophilin A. Leptin expression 
differed between the individuals studied. The strongest intensity of the PCR product 
was observed in the tongue, skeletal muscles, and stomach with moderate expression 
also being seen in the brain, testis and heart. Weak expression was observed in the skin 






                             Salamander1 (male, 22.5g) 
 
 
                            Salamander2 (female, 14.5g) 
 
 
                            Salamander3 (female, 22.4g) 
 
Figure 28 Tissue distribution of LEPR mRNA in the salamander using RT-PCR. For 
each individual, the distribution for cyclophilin mRNA is shown in the upper panel and 
for LEPR mRNA in the lower panel. Identical lanes were used for leptin and cyclophilin 
in each individual. Tissue abbreviations: Olf, olfactory bulb; Oesoph, oesophagus; Sk 
Msc, skeletal muscle; Upp SI, upper small intestine; Stom, stomach; Fat, fat body; 
Control (negative control - no template). 
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3.3.8 Quantitative tissue distribution of axolotl LEPR using real-time RT-PCR  
 
The expression pattern of LEPR between tissues was established by quantitative real-
time PCR in two different age groups of animals. The juveniles were 6-months old with 
no gonads developed; the adults were 3-years old. The tissue distribution of LEPR 
mRNA was broader in the juveniles compared with the adult animals (Figure 29A). In 
adults, expression differed significantly across tissues (F(9,42)=2.48, p=0.015) with the 
highest expression level detected in the brain and skeletal muscles. Expression in these 
two tissues was significantly higher than in the small intestine, spleen, fat, liver, heart 
and lung (p<0.05) (Figure 29B) which agrees with the qualitative RT-PCR results 
(Figure 27). In juveniles, LEPR expression also differed significantly across tissues 
(F(10,45)=2.78, p<0.05). The highest expression was in the skeletal muscle, brain and 
stomach, and did not differ significantly between these three tissues (P>0.05). 
Expression in the skeletal muscle and brain was significantly higher than in the small 
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   B 
 
Figure 29 Expression of LEPR in the axolotl. The tissue distribution in two different 
age groups of animals (A, juveniles, 6 month old; B, adults, 3 year old) was analyzed by 
quantitative RT-PCR. Leptin level was normalized to the expression of the cyclophilin 
gene. Bars represent means (including SEM). Asterisks indicate significant differences 
for the skeletal muscle and brain compared with the small intestine, spleen, fat, liver, 




In order to compare expression levels of LEPR between in the highest-expressing 
tissues between juveniles and the adults, another quantitative real-time PCR was 
performed. No significant differences were detected in tissue expression between the 
two age groups (F(1,18)=2.45, p>0.05) and there was no significant interaction between 
age and tissue expression (Figure 30). 
 
 




A partial sequence of an axolotl LEPR gene orthologue and its expression has been 
characterised. The predicted amino acid sequence shares 54-61% sequence similarity 
with mammalian LEPRs and 46% with the Xenopus LEPR. Northern hybridisation and 
RT-PCR analyses showed that the expression of the LEPR gene was widespread, 
including in embryonic tissues, with the highest expression being shown in the brain, 




The sequence similarity of the cloned LEPR fragment is as would be expected. The 
results from the phylogenetic tree of fish, amphibian, avian and mammalian LEPR 
sequences demonstrate that the evolutionary relationship between leptin receptor 
molecules is consistent with the accepted consensus of vertebrate evolutionary 
divergence and that the sequence found is naturally present in the axolotl rather than 
being a cloning artifact. The amino acid sequence identity with the Xenopus LEPR at 
46% is not close but is consistent with the 60% identify reported between the Tiger 
salamander and Xenopus leptin coding sequences (Boswell et al., 2006). The sequences 
of leptin and its receptor appear to be more conserved within salamanders because the 
leptin sequences of the axolotl and Tiger salamander are almost identical (Chapter 3) 
and the present study demonstrated that the cloned LEPR fragment is identical between 
the two species. In terms of the intron-exon structure of the axolotl LEPR, no evidence 
could be found in the present study, from PCR amplification of genomic DNA, for the 
presence of an intron in the cloned fragment. This was predicted by splice site 
prediction programs and also by sequence comparisons in the chicken and turkey and 
the pufferfish, where the fragment corresponds to the region between exons 11 and 12 
(Richards and Poch, 2003, Kurokawa et al., 2008). This suggests that if the cloned 
axolotl LEPR sequence is correct, the intron/exon structure may differ from that in other 
vertebrates. 
 
Further evidence that the cloned sequence does represent the axolotl LEPR is provided 
by the expression pattern observed in the present study. Northern hybridisation 
indicated that the gene is naturally expressed in the testis and that the axolotl LEPR 
transcript is approximately 3 kb in size. This lies close to transcript sizes reported in 
other animals, e.g. mouse, 4.5 kb; turkey, 4kb (Richards and Poch, 2003); Xenopus, 
3.4kb (Crespi and Denver, 2006); pufferfish, 3.3kb (Kurokawa et al., 2008). A single 
transcript was detected, suggesting that one splice variant is predominantly expressed in 
the axolotl. Among other non-mammalian vertebrates, a LEPR splice variant has been 
detected in birds although its physiological significance is uncertain (Liu et al., 2007) 
and five splice variants were identified in Atlantic salmon, only two of which contained 
the transmembrane domain (Ronnestad et al., 2010). 
 
The LEPR transcript is widely distributed among tissues, which suggests that leptin may 
have diverse physiological roles in amphibians as was also suggested for Xenopus 
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(Crespi and Denver, 2006). The strongest intensity of the PCR product was observed in 
the brain with moderate expression also being seen in the skeletal muscles and stomach. 
This finding agrees with the main sites of LEPR expression in mammals, and also in 
birds, Xenopus, and fish (Horev et al., 2000; Richards and Poch, 2003; Crespi and 
Denver, 2006; Kurokawa et al., 2008; Ronnestad et al., 2010) providing further 
evidence that the gene fragment cloned represents the axolotl LEPR. In all vertebrates, 
the LEPR is predominantly expressed in the hypothalamus, the part of the brain 
responsible for the control of food intake (Tartaglia et al., 1995). The expression pattern 
of the LEPR was similar to that of leptin, suggesting that leptin may have a paracrine 
function in these tissues. In mammals, gastric leptin is responsible for the short-term 
response to food intake mediated by satiety peptides such as cholecystokinin (Bado et 
al., 1998; Pico et al., 2003) and leptin expressed in skeletal muscle is involved in 
stimulation of glucose uptake (Cusin et al., 1998; Haque et al., 1999; Kamohara et al., 
1997; Minokoshi et al., 1999). In contrast, a hemocrine action of leptin is predicted in 
tissues where only the receptor is expressed (Crespi and Denver, 2006).  
 
In order to establish the expression pattern of LEPR between tissues more reliably, 
quantitative real-time PCR was performed in two different age groups of animals. The 
tissue distribution of LEPR mRNA was broader in juveniles compared with adult 
animals. The most widespread expression was observed in the smallest group of 
animals. In adults, the highest expression level was detected in the brain and skeletal 
muscles (Figure 29B) which agreed with the qualitative RT-PCR results (Figure 27). In 
juveniles, LEPR expression was high in the brain, skeletal muscles and stomach with 
moderate expression in the heart, skin, intestine, spleen and fat. Weak expression was 
observed in the liver and lung. However, when LEPR expression in skeletal muscle, 
stomach and brain was directly compared between the juvenile and adult animals by 
real-time PCR, no significant differences in expression with age were detected. In 
contrast, the analysis done for leptin in the fat, brain and heart shows that leptin 
expression is generally higher in the juveniles (Chapter 4). 
 
The cloned Tiger salamander LEPR cDNA fragment was identical to the axolotl 
receptor sequence suggesting that the LEPR has been conserved in these closely-related 
species.  Analysis of tissue expression was performed on the same cDNA samples used 
by Boswell et al. (2006) to characterise the leptin gene in the Tiger salamander. The 
LEPR tissue distribution was broader than that obtained for leptin expression in the 
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same animals (Boswell et al., 2006), however the expression pattern was similar with 
the highest levels in the brain, stomach, skeletal muscles and tongue (Figure 28). Faint 
LEPR expression was observed in the testis cDNA sample from the male salamander 
where strong leptin expression was reported in the previous study. However, although 
the skin showed strong leptin expression in one individual, it was not a site of LEPR 
expression. Overall, the tissue expression of the LEPR was very similar between the 
Tiger salamander and the axolotl, even though the Tiger salamanders sampled were 
metamorphosed animals. 
The fact that expression of LEPR was found in axolotl embryos before feeding stages 
and before adipose tissue formation (late gastrula stage) suggests a potential role for the 
leptin system in amphibian embryonic growth and development. These finding agree 
with developmental expression of leptin and its receptor in Xenopus tropicalis (Crespi, 
Denver, 2006) and also in the Zebrafish (Liu et al., 2010). Although LEPR expression 
was not localised to specific tissues in the present study, the main site of LEPR 
expression in the embryonic zebrafish was in the notochord (Liu et al., 2010).  In the 
present study a distinct peak in LEPR expression was observed around the time of 
hatching. Interestingly, a similar observation was made in the zebrafish when 
temporarily increased LEPR expression was associated with the switch in nutrition from 
yolk to external food and the transition to free swimming (Liu et al. 2010).  
 
The general observation of LEPR expression during development in the axolotl is 
consistent with studies in mammals implicating leptin in the growth and development of 
the fetus, both through placental and fetal expression of the leptin and leptin receptor 
genes (Hoggard et al., 1997; Takahashi et al., 1999; Schubring et al., 1996; Heaney et 
al., 1996). 
 
In conclusion, an axolotl cDNA fragment has been identified that shares similarities to 
characterised vertebrate LEPRs in its nucleotide and amino acid sequence and 
expression pattern. Conserved structure and function support the idea that the found 
sequence is orthologous to other vertebrate LEPRs. However, despite several attempts, 
using different methods, it was not possible to obtain a full-length cDNA sequence for 
the axolotl LEPR. The reasons for this are unclear. However, the similarity of the 
expression pattern to that observed in other vertebrates does provide compelling 








To investigate the molecular evolution of leptin, it is crucial to identified leptin-like 
molecules and its function in non-mammalian vertebrates. The first evidence to suggest 
that the leptin gene has been conserved in non-mammalian vertebrates was based on 
Southern hybridization of a mouse leptin probe to genomic DNA from chicken and eels 
(Zhang et al., 1994). Afterwards, the cloning of a chicken leptin cDNA was reported 
(Taouis et al., 1998, Ashwell et al., 1999) and indicated that the identified cDNA shared 
97% identity with mouse leptin at the amino acid level. The close similarity between 
mouse and chicken leptin induces doubt concerning the nature and origin of this 
sequence (Friedman-Einat et al., 1999, Dunn et al., 2001). Furthermore, analysis of the 
sequenced avian genomes suggests that leptin is absent (Pitel et al., 2010). However, 
there is evidence for a leptin-like gene in the genome of Anolis carolinensis (Boswell, 
2011) together with leptin-like immunoreactivity in tissues from Sceloporus undulates 
and Podarcis sicula (Niewiarowski et al., 2000, Paolucci et al., 2001; Paolucci et al., 
2006; Sciarrillo et al., 2005, Spanovich et al., 2005). 
 
Therefore, information on the evolution of the leptin signalling pathway and its 
functions in non-mammalian vertebrates is very limited. More is known about leptin in 
fish than other non-mammals, beginning with the identification and characterisation of 
the leptin gene in the pufferfish (Takifugu rubripes) (Kurokawa et al., 2005). Full length 
leptin genes have since been identified in the common carp (Cyprinus carpio) (Huising 
et al., 2006a), zebrafish (Danio rerio) (Gorrisen et al., 2009), Atlantic salmon (Salmo 
salar) (Ronnestad et al., 2010), arctic charr (Salvelinus alpinus) (Froiland et al., 2010) 
and grass (Ctenopharyngodon idellus) and silver carp (Hypophthalmichthys molitrix) 
(Li et al., 2010). In contrast to pufferfish and arctic charr, duplicate leptin genes have 
been identified in carp (Huising et al., 2006a; Li et al., 2010), zebrafish, medaka 
(Gorrisen et al., 2009) and Atlantic salmon (Ronnestad et al., 2010), which derived from 
whole-genome duplication early in the teleost lineage (Gorissen et al., 2009). The 
predicted fish leptin proteins show less than 25% amino acid sequence identity with 
mammalian leptins and the identity between pufferfish and carp leptins is only slightly 
higher (Huising et al., 2006a). The discovery of leptin genes in fish is in agreement with 
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the detection of leptin-like immunoreactivity in the blood, brain, heart, stomach and 
liver of green sunfish (Lepomis cyanellus), bluegill sunfish (Lepomis macrochirus), 
largemouth bass (Micropterus salmoides), white crappie (Pomonix annularis), channel 
catfish (Ictalurus punctatus), rainbow trout (Oncorhynchus mykiss) (Johnson et al., 
2000), sea bass (Dicentrarchus labrax), goldfish (Carassius auratus) (Russo et al., 
2010) and catshark (Scyliorhinus canicula) (Gambardella et al., 2010). 
 
Evidence for leptin-like genes in amphibians was presented shortly after the discovery 
of leptin genes in fish. Leptin genes have now been described for four amphibian 
species: the tiger salamander (Ambystoma tigrinum) (Boswell et al., 2006), the axolotl 
(Ambystoma mexicanum) (Boswell et al., 2006), Xenopus tropicalis (Crespi and Denver, 
2006), and Xenopus laevis (Crespi and Denver, 2006). The amphibian leptin genes share 
less than 35% amino acid identity to mammalian leptins. Although amphibian leptin 
was originally identified in the Tiger salamander, the axolotl is a more widely studied 
laboratory amphibian. It offers the opportunity to extend what is known about leptin in 
amphibians by allowing comparison with observations on the leptin gene expression in 
Xenopus (Crespi and Denver, 2006). The aim of this chapter is to use the axolotl leptin 
gene sequence to analyse the tissue distribution and developmental regulation of leptin 
gene expression. 
 




4.3.1 Cloning of axolotl leptin 
 
A partial cDNA sequence corresponding to a putative leptin gene was isolated from an 
axolotl hatched larvae. Primers were designed to amplify a fragment of axolotl leptin 
cDNA and the resulting sequence information was compared to an axolotl EST clone 
deposited in GenBank (Accession No. CO792338). The 425-bp fragment encodes 111 
amino acid residues. The cDNA fragment isolated by PCR was 98.8% identical to the 
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EST sequence, differing by 5 gaps (at positions: 502, 520, 568, 580, 581 in axolotl EST 
sequence) and 5 substitutions (at positions: 425, 476, 551, 583, 584 in axolotl EST 
sequence). Furthermore, the axolotl cloned sequence shared 99% with salamander leptin 
(DQ64637) and differed by an A to G synonymous substitution at position 281 in the 
axolotl sequence (at position 476 in salamander sequence). The cDNA identified shares 
67% with Xenopus laevis, 37% with human leptin, and 6-25% with fish leptins. 
 
 
Figure 31 Nucleatide and amino acid sequence of leptin gene from axolotl. The 
positions of the primers in the nucleotide sequence are in bold and underlined. An A to 
G substitution compared to the Tiger salamander and axolotl EST CO792338 is shown 
in red. The predicted amino acid sequence does not include the primers.  
 
To investigate the leptin gene structure, PCR amplification of axolotl genomic DNA 
was performed with the same primers used for cDNA amplification. This yielded a 4.5 
kb fragment (Figure 32). In contrast, a 409 bp product was obtained using a cDNA 
template, indicating that the cloned leptin fragment contained introns. Furthermore, 
splice site prediction programs (www.fruitfly.org/seq_tools/splice.html; 
http://www.cbs.dtu.dk/services/NetGene2/) predicted an exon-intron boundary with 
confidence scores of 0.55 and 0.77, respectively (at nucleotide positions 76-116; 86-
106). The predicted splice donor and acceptor site corresponds to the position of the 






Figure 32 Amplification of axolotl genomic DNA. Lane 1 represents generated 
amplification product (4.5 kb) from 300 ng axolotl genomic DNA template. M 
designates size marker and lane 2 represents no template control. 
 
 
Figure 33 Amino acid alignment of vertebrate leptin on the basis of amino acid 
sequences of leptin in human (Homo sapiens; AAH69323), cow (Bos taurus; 
CAD54745), sheep (Ovis aries; Q28603), mouse (Mus musculus; ADM72802), dog 
(Canis familiaris; BAA35129), Xenopus leavis (NP_001089183), salamander 
(Ambystoma tigrinum;AAY68394) and zebrafish (Danio rerio;NP_001122048) 




4.3.2 Molecular phylogeny 
 
Phylogenetic analysis of leptin was performed in order to gain insight into the 
evolutionary history of this protein. Deduced amino acid sequences were compared to 
the equivalent region of leptin sequences available in GenBank. The alignments were 
used to construct a phylogenetic tree, which shows that the accepted evolutionary 
relationships between the species analyzed are consistent with the consensus view of 


















Figure 34 A phylogenetic tree (phylogram) was constructed on the basis of  amino acid 
sequences of leptin in human (Homo sapiens; AAH69323), cow (Bos taurus; 
CAD54745), mouse (Mus musculus; ADM72802), dog (Canis familiaris;BAA35129), 
Anolis carolinensis (XP003229128), Xenopus leavis (NP_001089183), salamander 
(Ambystoma tigrinum;AAY68394), medaka (Oryzias latipes;BAD94448), pufferfish 
(Takifugu rubripes; BAD94444), axolotl (Ambystoma mexicanum), human growth 
hormone (GH; PO1241), and mouse growth hormone (GH; PO6880). The tree was 
calculated using the Maximum Likelihood method based on the Equal Input model 
(Tajima and Nei, 1984). The tree with the highest log likelihood (-3627.7182) is shown. 
The analysis involved 12 amino acid sequences. There were a total of 136 positions in 
the final dataset. Evolutionary analyses were conducted in MEGA5 (Tamura et al., 
2011). Numbers at branch points represent the bootstrap value for 1000 replicates as 
percentages and indicate the statistical reliability of a node in the tree.  Human and 







4.3.3 Northern analysis 
 
To investigate the presence of leptin in axolotl, Northern hybridization was carried out 
using poly(A)+ RNA extracted from axolotl testis. Radioactive detection was performed 
using RNA from the testis hybridized with axolotl leptin oligonucleotide probes 




Figure 35 Northern hybridization of leptin poly(A)+RNA isolated from axolotl testis. A 
9 µg aliquot of poly(A)+ RNA was electrophoresed through a 1% agarose formaldehyde 
gel, transferred to a nylon membrane, and hybridized with 32P-labeled antisense axolotl 
leptin receptor oligonucleotides. The hybridization signal was obtained after 2 week 
exposure to a film. 
 
4.3.4 Developmental expression of the leptin gene during axolotl embryogenesis 
 
The developmental expression of leptin mRNA in the axolotl was analyzed by 
qualitative RT-PCR. Leptin expression was not detectable during early development 
(neurulation) and tailbud stages (stages 29-32), however it increased markedly around 
the time of hatching (stages 41-43) so that it was detected only in the two last stages of  




Figure 36 Developmental expression of leptin in the axolotl. Qualitative RT-PCR 
analysis of leptin during embryogenesis and early larval development. Amplification of 
cyclophilin indicates the presence of cDNA at the different developmental stages. M 
indicates DNA size ladder; NC – negative controls; the numbers – developmental 
stages. 
 
4.3.5 Tissue expression of axolotl leptin gene using RT-PCR 
 
The distribution of axolotl leptin expression was studied by RT-PCR on mRNA isolated 
from a variety of tissues in three different age groups of animals: 6 months old (no 
gonad development), 10 months old, and adults. Leptin expression differed between the 
individuals studied. The most widespread expression was observed in the youngest 
group of animals (Figure 37A). The strongest intensity of the PCR product was 
observed in the fat body and heart with moderate expression also being seen in the skin, 
skeletal muscles, and stomach. Weak expression was observed in the spleen, kidney and 
lungs. In the largest, adult, animals, leptin expression was detected mainly in the gonads 
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Figure 37 Tissue distribution of leptin mRNA in the axolotl using RT-PCR. 
Distribution is shown in representatives from three different age groups of animals (A, 
6-month old animal; B, 10-month old male; C, 3-year old male). For each individual, 
the distribution for cyclophilin mRNA is shown in the upper panel, and for leptin 
mRNA in the lower panel. Identical lanes were used for leptin and cyclophilin in each 
individual. Note that the tissues sampled vary between individuals. Tissue 
abbreviations: Sk Msc, skeletal muscle; Mid SI, mid small intestine; Stom, stomach; 
Fat, fat body; NC, negative control (no template); PC, positive control.  
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4.3.6 A quantitative real-time RT-PCR assay for axolotl leptin  
 
The expression pattern of leptin between tissues was established by quantitative real-
time PCR in two different age groups of animals. The juveniles were 6-months old with 
no gonads developed; the adults were 3-years old. The tissue distribution of leptin 
mRNA was broader in the juvenile axolotls compared with the adult animals. In adults, 
the highest expression level was detected in the brain, fat, heart and testis (Figure 38B), 
which agrees with the qualitative RT-PCR results (Figure 37C), however expression did 
not differ significantly across tissues (F(9,38)=2.136, p=0.059). In contrast, in juveniles, 
leptin expression differed significantly across tissues (F(9,46)=2.291, p=0.37). The 
highest expression was in the fat body, which was significantly higher than in the 






























Figure 38 Expression of leptin in the axolotl. The tissue distribution in two different 
age groups of animals (A, juveniles, 6 month old; B, adults, 3 year old) was analyzed by 
quantitative RT-PCR. Leptin level was normalized to the expression of the cyclophilin 
gene. Bars represent means (including SEM). Asterisk indicates significant differences 
for the fat compared with the skeletal muscles, small intestine, stomach, brain, spleen, 
liver and lung (Fisher’s least significant difference test; p<0.05). 
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In order to compare leptin expression levels between the juvenile animals and the 
adults, another quantitative real-time PCR was performed. Leptin expression across 
tissues was significantly (F(1,14)=5.65, p<0.05) higher in the juvenile animals, but no 
significant differences were detected by post hoc comparisons between individual 
tissues (Figure 39). 
 
Figure 39 Comparison of expression levels of leptin between juveniles and adults 
 
4.4 Discussion 
An axolotl leptin-like molecule and its expression has been characterised. The identified 
sequence shares similarities on structural and expression pattern levels with mammalian 
leptin genes. The predicted amino acid sequence showed 37% identity with human 
leptin, 67% with Xenopus leptin and 99% with Tiger salamander leptin. The highest 
expression level was found in the fat, brain, heart and testis by analysing results from 
Northern blot, RT-PCR and real-time PCR. 
 
The phylogenetic tree of mammalian, amphibian and fish leptin sequences shows that 
the identified sequence in naturally present in the axolotl and that the accepted 
evolutionary relationships between the species analysed are consistent with the 
consensus view of vertebrate evolution. A very high identity at the nucleotide level of 
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98% was found between the leptin fragment cloned and the equivalent sequence from 
the Tiger salamander and another axolotl EST sequence indicating that leptin has been 
highly conserved in these closely-related species. As previously shown in the Tiger 
salamander (Boswell et al., 2006) the axolotl leptin coding sequence studied contained 
an intron, as demonstrated by PCR amplification of genomic DNA. However, the 
evolutionary distance between the axolotl and the Tiger salamander corresponded to a 
difference in the size of the intron – the fragment amplified was 4.5 kb in the axolotl 
and 6 kb in the Tiger salamander. The general finding that the leptin coding sequences 
contains two exons is consistent with mammalian (He et al., 1995) and fish (Kurokawa 
et al., 2005) leptin gene structure. 
 
Northern hybridisation analysis demonstrated that the axolotl leptin transcript lies 
within the range of transcript sizes reported in other animals (human - 3.4 kb; mouse - 
4.5 kb; bat – 2.3 kb; Tiger salamander – 1.9 kb) (He et al., 1995; Zhao et al., 2003; 
Boswell et al., 2006). This result shows that the cloned gene is naturally expressed in 
the testis. 
 
The expression pattern of leptin between tissues was established by quantitative real-
time PCR in two different age groups of animals. The tissue distribution of leptin 
mRNA was broader in the juveniles compared with the adult animals. In juveniles, the 
strongest intensity of the PCR product was observed in the fat body and heart with 
moderate expression also being seen in the skin, skeletal muscles, and stomach. Weak 
expression was observed in the spleen, kidney and lungs. In adult axolotls leptin 
expression was detected mainly in the fat, testis and heart. In the closely-related tiger 
salamander (investigated in three individuals by qualitative PCR), the highest leptin 
mRNA was observed in the skin and testis and moderate expression in the brain, 
stomach, small intestine, colon, skeletal muscle, tongue, and fat body (Boswell et al., 
2006). Thus the general pattern of expression was comparable between the two species, 
although stronger expression was observed in the skin in the tiger salamander, and no 
leptin expression was reported in the heart. When leptin expression in the fat, brain and 
heart was directly compared, between juvenile and adult axolotls the overall level of 
leptin expression across tissues was significantly higher in the juveniles. This may be 
linked to the general observation of more widespread leptin expression across tissues in 
both axolotls and tiger salamanders, and suggests that leptin gene expression may be 
developmentally regulated in salamanders (Boswell et al., 2006). In contrast, however, 
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the analysis done for LEPR in the brain, skeletal muscles and stomach demonstrated no 
significant difference in expression with age (Chapter 3). 
 
The general pattern of leptin expression in salamanders is generally comparable with 
observations in Xenopus laevis, even though the amino acid sequence similarity 
between the two species is only 60%. In Xenopus, the strongest intensity of leptin 
expression was detected in the brain and heart but also in liver, brain, pituitary gland, 
heart, gastrointestinal tract, lungs, kidney, and gonads (Crespi and Denver, 2006). 
Amphibans and teleost fish show more widespread tissue distribution of leptin 
expression compared to mammals, suggesting a wider range of leptin functions. In 
teleost fish, the liver is consistently a strong site of leptin expression and adipose tissue 
weak (Copeland et al. 2011). Conversely, in amphibians, expression is more mammal-
like in that expression is greater in adipose tissue compared to liver. This may be related 
to metabolic differences between these ectothermic taxa.  
 
In addition to the fat body, the most prominent sites of leptin expression in the axolotl 
were the heart, brain and testis. The expression of leptin in the heart may be related to 
reports in mammals of a hypertrophic effect of the hormone on cardiac muscle cells 
(Karmazyn et al., 2007) while leptin acts in the mammalian brain to regulate neuronal 
plasticity and excitability (Harvey, 2007). Moderate leptin expression was observed in 
the testis in the sexually mature axolotls and strong expression in the tiger salamander. 
Reports of leptin expression in the testis are rare in mammals, although it has been 
linked to testicular development in the mouse (Herrid et al., 2008). As leptin expression 
was also prominent in the gonads of Xenopus laevis, the local production of leptin may 
be more significant in controlling gonadal function in amphibians compared to 
mammals. It was observed that in the axolotl, the fat body is situated next to the testis 
and is reduced in size as the testes develop suggesting interplay between these organs 
during reproductive development where leptin may act as a link between adipose tissue 
and the reproductive system. 
 
During axolotl embryonic development, leptin expression was found before feeding 
stages and before adipose tissue formation (late gastrula) and it increased markedly 
around the time of hatching. This finding suggests a potential role for the leptin system 
in amphibian embryonic growth and development, which agrees with developmental 
expression of leptin in Xenopus tropicalis (Crespi and Denver, 2006) and also in the 
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Zebrafish (Liu et al., 2010). It is likely that the peak in leptin expression at hatching, 
associated with the transition to free-feeding is linked to the establishment of brain 
circuits controlling energy metabolism. For example, in Atlantic salmon, a peak in 
leptin expression was observed in the head after the larvae starting feeding which was 
associated with peaks in expression of the POMC and CART genes known to be 
regulated by leptin in mammals (Moen et al., 2010).  
 
In conclusion, an axolotl cDNA fragment has been identified that shares similarities to 
other characterised vertebrate leptins in its nucleotide and amino acid sequence and 
expression pattern. Identification of leptin-like genes in amphibians and fishes 
demonstrates that leptin is of ancient origin in vertebrates rather than having evolved 
recently in mammals. The more widespread expression of leptin in amphibians and fish, 
including prominent expression in tissues other than fat, suggest a wider range of leptin 




























In order to understand the possible role(s) of leptin in the regulation of food intake and 
energy metabolism in amphibians, it is essential to study changes in leptin expression 
due to nutritional state. The effects of feeding status in non-mammalian vertebrates have 
been mostly investigated in fish. Leptin gene expression has been studied in carp 
(Huising et al., 2007a), rainbow trout (Kling et al., 2009) and Atlantic salmon 
(Rønnestad et al., 2010) in response to short and long-term fasting, refeeding and 
feeding to satiation. Leptin expression was unaffected by fasting, feeding to satiation or 
refeeding in carp (Huising et al., 2007a), unlike the situation in mammals where fasting 
decreases leptin expression, and refeeding increases it (Saladin et al., 1995). In contrast, 
long-term food restriction in Atlantic salmon lowered expression of the lep-A1 
transcript in the fat and white muscle, however plasma concentrations of salmon leptin 
did not show any difference. The same results were obtained from rainbow trout (Kling 
et al., 2009). Moreover, increased leptin expression was observed after ingestion of a 
single scheduled meal, providing evidence that leptin may act as a short term signal of 
satiety in carp (Huising et al., 2007a). This result correlates to the postprandial increase 
in leptin mRNA that is observed in the hours following feeding in mice (Saladin et al., 
1995) and is in agreement with the observation of an inhibitory effect on food intake 
following injection of recombinant mammalian leptin into the  goldfish brain (Volkoff 
et al., 2003). 
 
Thus, leptin mRNA expression in fish is altered by changes in food intake, but there is 
limited evidence for involvement of leptin in the long-term regulation of food intake 
and energy metabolism as is the case in mammals (Huising et al., 2006a). These 
findings may be related to the differences in energy metabolism between endotherms 
and ectotherms. Ectotherms do not need to thermoregulate, thus their metabolic 
regulation is more flexible (Huising et al., 2006). For this reason the physiological role 
of leptin in ectotherms may differ quantitatively, if not qualitatively, from its role in 
mammals. However, this has not been tested in ectothermic vertebrates outside fish. 
Although the effects of leptin on feeding behaviour have been studied in Xenopus laevis 
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(Crespi and Denver, 2006), the effects on nutritional state on leptin gene expression 
have not yet been studied in amphibians. To address this, the effects of feeding status 
and mRNA levels in selected tissues were examined in two groups of axolotls which 
had been either fed to satiation (every day), or fed every other day for 14 days. If leptin 
expression is regulated in a similar way to mammals, a significantly higher level of 
leptin expression would be expected in the fed, compared to the restricted-fed group. 
 
5.2 Materials and methods 
 
Axolotls (6 months old) were purchased from The Ambystoma Genetic Stock Centre, 
University of Kentucky, USA and were maintained at the Comparative Biology Centre, 
Newcastle University. Five days after arrival in Newcastle, during which they were 
allowed to recover and acclimatise, the axolotls were divided into two groups of twelve 
animals. They were housed individually in tanks at 20˚C in dechlorinated tap water, and 
were fed commercial amphibian pellets. The first group was fed to satiation (every day) 
and the second group was fed every other day over a 14-day period. At the end of the 
experiment, the animals were humanely killed at 24 h after the last feeding time by 
immersion in 0.1% tricaine methane-sulfonate (ethyl 3-aminobenzoate methane-
sulfonate) anaesthetic (Sigma, Poole, Dorset, UK), in accordance with the United 
Kingdom Home Office Code of Practice. Following dissection, tissues were 
immediately incubated in RNAlater (Ambion, Applied Biosystems, Warrington, 
Cheshire, UK), stored at 4˚C overnight, and were then frozen and stored at -80˚C.  
 
Nucleic acid extraction, cDNA synthesis, RTqPCR analysis for leptin and LEPR and 
statistics were performed according to the General Methods Chapter. 
 
PCR was also carried out to amplify a cDNA fragment of axolotl NPY. Primers were 
designed based on an axolotl NPY EST deposited in GenBank (Accession No. 
 AY660754). The primers used were: forward primer 5’-
TGCTAACCTTTGCCCTGTCT, AxNPYF1 (positions 168-187 of Accession 
No. AY660754), and reverse primer 5’-GATCACCAAACCGGGATCTA, AxNPYR1 
(positions 407-416 of Accession No.  AY660754) yielding reaction product: 249 bp. 
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PCR for cyclophilin A cDNAs was performed as described in the General Methods 
Chapter with an annealing temperature of 60°C and denaturing and extension steps of 
94°C and 72°C, respectively. Times used were 15 sec denaturation, 30 sec annealing, 
and 30 sec extension, with an extension time for the final cycle of 7 min. PCR was 




5.3.1 Body mass 
 
The effect of the nutritional manipulation was demonstrated by the differences in body 
mass between control and restricted-fed axolotls. Restricted feeding for 14 days (fed 
every other day) resulted in significantly lower body mass and length (p<0.001) 
compared to normally fed axolotls (fed every day) (Figure 40). Fed axolotls increased 
from 5.79 ± 0.19 to 12.48 ± 0.5 g during the14-day experimental period, while 
restricted-fed axolotls exhibited a gain in body mass from 5.94 ± 0.24 to 7.96 ± 0.29 g. 
Thus there was a 47.6% increase in body mass in the fed group, compared to a 25.9% 
increase in the restricted-fed group.  
 
5.3.2 Leptin and LEPR expression 
 
Expression of leptin and LEPR were investigated in fat, brain and heart for leptin, and 
brain, stomach and skeletal muscles for LEPR because gene expression had previously 






Figure 40 Effect of restricted feeding for 14 days on axolotl size. Bars represent means 
(including SEM). Asterisks indicate significant differences in body mass and length 
between fed and restricted-fed groups of animals (Fisher’s least significant difference 
test; p<0.001). 
 
In all analysed tissues there was a tendency towards a lower leptin and LEPR 
expression of restricted-fed axolotls, although no significant differences were detected 
in any tissue between the groups. Analysis for leptin expression in fat and brain 
demonstrated a trend for higher leptin expression in the fed group (Fat: F(1,18)=2.068; 
P=0.169; Brain: F(1,18)=1.559; P=0.229) (Figure 41A). The expression of leptin in 
heart was not detectable. Expression of LEPR in brain and skeletal muscles was also not 
affected by feeding regime, however showed a tendency towards a higher expression in 
the fed group of animals (Skeletal muscle: F(1,20)=0.000, P=0.992; Brain: 














Figure 41 Effect of restricted feeding of axolots for 14 days on leptin (A) and LEPR 
(B) expression in selected tissues. Leptin and LEPR levels were normalized to the 




5.3.3 NPY expression 
 
NPY gene expression is regulated by leptin in mammals and was investigated here as an 
additional marker of nutritional status, Higher NPY expression was found in the 
restricted-fed group of animals, however there was no significant difference between the 
groups (F(1,15)=2.211; P=0.159). 
 
 
Figure 42 Effect of restricted feeding of axolotls for 14 days on NPY expression in the 
brain. NPY mRNA levels were normalized to the expression of the cyclophilin gene. 




From mammalian studies (Saladin et al., 1995), it would be predicted that leptin 
expression would be higher in the fully fed axolotls compared to the restricted-ffed 
animals. However, no significant differences were found in leptin and LEPR expression 
between the experimental groups, suggesting that the nutritional regulation of these 




The impact of the nutritional manipulation was demonstrated by a significant difference 
in body mass between the fed and restricted-fed animals. Axolotls that were fed to 
satiation grew twice as fast as restricted animals. However the clear difference in 
nutritional state was not reflected in increased leptin expression in the fed group at the 
termination of the experiment. Moreover, after 14 days of fasting, the brain expression 
of orexigenic NPY was not significantly changed, however it showed a tendency 
towards higher NPY expression level in fasted animals. This results show similarity 
with mammalian model, where leptin decreases NPY expression and it the same time 
reduces food intake (Lewis et al., 1993; Mizuno and Mobbs, 1999; Stephens et al., 
1995). However, because the difference was not significant, it is unclear whether NPY 
gene expression is regulated by leptin in amphibians as it is in mammals. 
 
Thus, the effects of manipulating the feeding level in axolotls more closely resembles 
the situation in some teleost fish studies where leptin gene expression was unaffected by 
fasting, feeding to satiation or refeeding (Huising et al., 2006a; Rønnestad et al., 2010). 
This constrasts to the situation in mammals, where fasting decreases leptin expression, 
and refeeding increases it (Saladin et al., 1995). Thus, leptin mRNA expression in fish 
is altered by changes in food intake, but there is limited evidence for involvement of 
leptin in the long-term regulation of food intake and energy metabolism as is the case in 
mammals (Huising et al., 2006a). 
 
 Collectively these findings may be related to the differences in energy metabolism 
between endotherms and ectotherms. Ectotherms do not need to thermoregulate, thus 
their metabolic regulation is more flexible (Huising et al., 2006a). For this reason the 
physiological role of leptin in ectotherms may differ quantitatively, if not qualitatively, 
from its role in mammals. 
 
For further study, the design of the experiment should be changed. The fasting period 
may not have been long enough to significantly decrease leptin expression level of the 
restricted-fed group. Both groups at the termination of the experiment had food present 
in the stomach, which indicates that there is scope for a greater degree of food 
restriction. The timing of killing the animals may also have influenced the results 
because both groups had been fasted for 24 h. If the fed group had received food shortly 
before they were killed, it is possible that increased leptin expression may have been 




In conclusion, short-term fasting did not result in any significant changes in leptin 
expression in the restricted-fed animals, however it showed a tendency towards lower 
leptin and LEPR expression in the restricted fed axolotls. These are the first data on the 
regulation of leptin expression in amphibians. The results indicate that the regulation of 
leptin expression by nutritional state more closely resemble the situation in other 
ectotherms such as teleost fish. However, there were trends for leptin and NPY gene 
expression to change in a similar pattern to mammalian studies, so further experiments 
need to be performed in amphibians to confirm whether there is indeed a distinct pattern 




































Chapter 6. Concluding Summary 
 
Until 2005, leptin-like molecules had only been identified in mammals, so that little is 
known about the molecular evolution of the hormone and its functions. However, in the 
last five years, more information has become available as leptin and leptin receptor 
genes have been sequenced in fish, amphibians and reptiles. Most of the research on 
leptin in non-mammalian vertebrates is being performed in fish, though research on 
amphibians is very limited by comparison. 
 
Partial cDNAs corresponding to putative leptin and leptin receptor genes from axolotl 
hatched larvae were isolated and sequenced. The partial leptin (425bp) and leptin 
receptor (248bp) cDNA sequences share 37% and 61% identities, respectively, with 
human leptin at the amino acid level. Data from phylogenetic analysis, Northern blot, 
RT-PCR and RTqPCR analysis have shown that the cloned fragments are not artifacts 
and are naturally expressed in the axolotl.  
 
Cloning the axolotl LEPR was a key component of the work because no sequence 
information was previously available. A year was devoted to attempting to obtain full-
length sequence for the LEPR using PCR, 3’- and 5’-RACE, and DNA walking 
methods but these were not successful for reasons that remain unclear.  
 
Despite the unsuccessful attempts to obtain the full-length axolotl LEPR sequence, the 
evidence presented in this thesis strongly suggests that the cloned fragment is indeed a 
natural ortholog of the mammalian LEPR. The phylogenetic analysis indicates that the 
axolotl LEPR groups with the Xenopus LEPR, consistent with the consensus view of 
vertebrate evolution. Furthermore, Northern hybridisation detected a transcript size of 
approximately 3kb, which lies within the range of transcripts reported in Xenopus and 
teleost fish  and shows that the LEPR gene is naturally expressed in the testis. Only a 
single transcript was detected in axolotl testis polyA+ RNA, suggesting the presence of 
a single splice variant in that tissue at least. The existence of alternative splicing of the 
LEPR, observed in mammals, birds, and teleost fish, has not been reported in 
amphibians, so its significance for this Class remains to be determined. 
 
Importantly, the LEPR tissue distribution, with the highest expression in the brain and 
skeletal muscles, agrees with the main sites of LEPR expression in mammals, and also 
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in birds, Xenopus, and fish (Horev et al., 2000; Richards and Poch, 2003; Crespi and 
Denver, 2006; Kurokawa et al., 2008; Ronnestad et al., 2010), where leptin receptor is 
predominantly expressed in the hypothalamus, the part of brain responsible for the 
control of food intake, implicating conserved function of LEPR. This finding suggested 
conserved function of LEPR and provides further evidence that the gene fragment 
cloned represents the axolotl LEPR. In addition, LEPR expression in axolotl embryos 
before feeding stages and before adipose tissue formation indicates that leptin signalling 
pathway may be involved in amphibian embryonic growth and development, showing 
that leptin may have diverse physiological roles in amphibians. These finding agree 
with developmental expression of leptin and its receptor in Xenopus tropicalis (Crespi, 
Denver, 2006) and also in the Zebrafish (Liu et al., 2010). The increased expression of 
both leptin and the LEPR around the time of hatching in all three species may be 
particularly significant because this is associated with the time that larvae are making 
the transition from internal to external food sources and are beginning free-swimming. 
Thus, leptin signaling may play an important role in this developmental transition. 
 
To investigate the cell types in which leptin and the LEPR were expressed in the 
axolotl, several months were spent working on in-situ hybridisation (using both isotopic 
and non-isotopic approaches). The aim of this experiment was to localize leptin and 
LEPR mRNA within the axolotl tissues showing the highest expression of leptin and its 
receptor, as was reported recently for the zebrafish LEPR (Liu et al., 2010). However, it 
was not possible to detect hybridisation reliably, even when control probes such as 
oligo(dT) were used to detect all mRNAs, and different methods of tissue preservation 
were tested. The approach of using specific antibodies was not achievable due to a lack 
of antibodies against amphibian leptin and LEPR. It would have been preferable to have 
performed this work in a laboratory optimised for in situ hybridisation but unfortunately 
this was not possible. 
 
The work presented in this thesis provides compelling evidence that the cloned 
fragments in the present study represent the axolotl leptin and its receptor. This has laid 
a platform for future investigations centred on the function of axolotl leptin and the 
LEPR.  
Furthermore, in order to understand the possible role(s) of leptin in the regulation of 
food intake and energy metabolism in amphibians, changes in leptin and LEPR 
expression were investigated due to nutritional state. The effects of feeding status on 
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leptin and the LEPR in non-mammalian vertebrates have been confined to teleost fish, 
where leptin expression increased (Kling et al., 2009) or was unaffected by fasting, 
feeding to satiation or refeeding (Huising et al., 2007a; Rønnestad et al., 2010), unlike 
the situation in mammals where fasting decreases leptin expression, and refeeding 
increases it (Saladin et al., 1995). The impact of the nutritional manipulation was 
demonstrated by a significant difference in body mass between the fed and restricted-
fed animals. Axolotls that were fed to satiation grew twice as fast as restricted animals. 
However, short-term fasting did not result in any significant changes in leptin 
expression in the restricted-fed animals, nevertheless it showed a tendency towards 
lower leptin and LEPR expression of fasted axolotls. Moreover, the brain expression of 
orexigenic NPY was not significantly changed, however it showed a tendency towards 
higher NPY expression level in fasted animals. This results show similarity with 
mammalian model, where leptin decreases NPY expression and it the same time reduces 
food intake (Lewis et al., 1993; Mizuno and Mobbs, 1999; Stephens et al., 1995). These 
findings indicate that the regulation of leptin expression by nutritional state more 
closely resemble the situation in other ectotherms such as teleost fish. Ectotherms do 
not need to thermoregulate, thus their metabolic regulation is more flexible (Huising et 
al., 2006). For this reason the physiological role of leptin in ectotherms may differ 
quantitatively, if not qualitatively, from its role in mammals. 
 
Comparative studies on leptin are needed to understand its function in all vertebrates 
and invertebrates. The aim of the present study is to increase an understanding of the 
physiological effects, diversity of functions and evolutionary history of leptin. 
Identification of leptin-like genes in amphibians, conserved structure and function 
demonstrate that leptin is of ancient origin, rather than this hormone has evolved 
recently in mammals. This thesis provides opportunity to investigate the functions of the 
leptin signalling system in these early tetrapod vertebrates, providing insight into the 
functional development of the system during vertebrate evolution. 
 
6.1 Future work 
 
The cloned region of LEPR is part of the extracellular domain. The full length LEPR 
isoform containing the extracellular and transmembrane domains together with 
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intracellular motifs is considered to be the fully functional receptor. In additional, 
shorter, isoforms the intracellular domain is truncated or absent (Richards and Poch, 
2003). Several isoforms of LEPR genes were identified in mammals (Cioffi et al., 
1996), chicken (Horev et al., 2000) and teleosts (Cao et al., 2011; Wong et al., 2007). 
Therefore, full-length sequence of LEPR should be cloned, and intracellular region 
should be used for the gene expression assay. Obtaining the full sequence awaits the 
sequencing of the axolotl genome, although this is not straightforward owing to its large 
size compared to other vertebrates (Voss et al., 2001). It is possible that a traditional 
cDNA library screening approach may be more successful. 
 
Moreover, to investigate the cell types in which leptin and the LEPR were expressed in 
the axolotl and to localize leptin and LEPR mRNA within the axolotl tissues, in-situ 
hybridisation should be performed.  
 
Furthermore, to investigate evolutionary conversation of leptin action on food intake 
regulation and metabolism, the effect of leptin administration should be studied. The 
expected results of this study would be reduction of food intake and body weight loss 
(Schwartz et al., 1996), however administration of leptin in fish showed unexpected 
effects (Baker et al., 2000, Londraville et al., 2002) compared with information about 
leptin in mammals. In contrast, intracerebroventricular injections of recombinant 
Xenopus leptin strongly decreased food intake in juvenile frogs, and tadpoles were only 
sensitive to the inhibitory effects of exogenous leptin from the midprometamorphic 
developmental stage (Crespi and Denver, 2006). These results support the conservation 
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